Amedeo Smart

Free Medical Literature Service


 

Amedeo

Drug Resistance

  Free Subscription

Articles published in
Antimicrob Agents Chemother
    August 2021
  1. PETRAITIS V, Petraitiene R, Kavaliauskas P, Naing E, et al
    Pharmacokinetics, Tissue Distribution, and Efficacy of VIO-001 (Meropenem/Piperacillin/Tazobactam) for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia in Immunocompetent Rabbits with Chronic Indwelling Vascular Catheters.
    Antimicrob Agents Chemother. 2021 Aug 30:AAC0116821. doi: 10.1128/AAC.01168.
    >> Share

  2. HOWARD-ANDERSON J, van Duin D
    Uncertainty in evaluating treatment outcomes in carbapenem-resistant Acinetobacter baumannii infections.
    Antimicrob Agents Chemother. 2021 Aug 23:AAC0142421. doi: 10.1128/AAC.01424.
    >> Share

  3. MUKHERJEE S, Blankenship HM, Rodrigues JA, Mosci RE, et al
    Antibiotic susceptibility profiles and frequency of resistance genes in clinical Shiga toxin-producing Escherichia coli isolates from Michigan over a 14-year period.
    Antimicrob Agents Chemother. 2021 Aug 23:AAC0118921. doi: 10.1128/AAC.01189.
    >> Share

  4. WANG CH, Siu LK, Chang FY, Tsai YK, et al
    Erratum for Wang et al., "A Novel Deletion Mutation in pmrB Contributes to Concurrent Colistin Resistance in Carbapenem-Resistant Escherichia coli Sequence Type 405 of Clinical Origin".
    Antimicrob Agents Chemother. 2021;65:e0137421.
    >> Share

  5. WEI J, Wen Y, Tong K, Wang H, et al
    Local Application of Vancomycin in One-Stage Revision of Prosthetic Joint Infection Caused by Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2021;65:e0030321.
    >> Share

  6. ABDUL-MUTAKABBIR JC, Nguyen L, Maassen PT, Stamper KC, et al
    In Vitro Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021;65:e0264620.
    >> Share

  7. CHOQUET M, Lohou E, Pair E, Sonnet P, et al
    Efflux Pump Overexpression Profiling in Acinetobacter baumannii and Study of New 1-(1-Naphthylmethyl)-Piperazine Analogs as Potential Efflux Inhibitors.
    Antimicrob Agents Chemother. 2021;65:e0071021.
    >> Share

  8. GILL CM, Aktathorn E, Alfouzan W, Bourassa L, et al
    Elevated MICs of Susceptible Anti-Pseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization.
    Antimicrob Agents Chemother. 2021 Aug 16:AAC0120421. doi: 10.1128/AAC.01204.
    >> Share

  9. NGWALERO P, Brust JCM, van Beek SW, Wasserman S, et al
    Relationship between plasma and intracellular concentrations of bedaquiline and its M2 metabolite in South African patients with rifampin-resistant TB.
    Antimicrob Agents Chemother. 2021 Aug 9:AAC0239920. doi: 10.1128/AAC.02399.
    >> Share

  10. JEHANNE Q, Benejat L, Ducournau A, Domingues-Martins C, et al
    Emergence of erythromycin resistance methyltransferases in Campylobacter coli strains in France.
    Antimicrob Agents Chemother. 2021 Aug 9:AAC0112421. doi: 10.1128/AAC.01124.
    >> Share

  11. HORWICH-SCHOLEFIELD S, Lloyd T, Varghese V, Yette E, et al
    Imipenem-Relebactam Susceptibility and Genotypic Characteristics of Carbapenem-Resistant Enterobacterales (CRE) Identified during Population-Based Surveillance.
    Antimicrob Agents Chemother. 2021 Aug 9:AAC0228820. doi: 10.1128/AAC.02288.
    >> Share

  12. PRUSSING C, Canulla T, Singh N, McAuley P, et al
    Characterization of the first carbapenem-resistant Pseudomonas aeruginosa clinical isolate harboring blaSIM-1 from the United States.
    Antimicrob Agents Chemother. 2021 Aug 2:AAC0106621. doi: 10.1128/AAC.01066.
    >> Share

    July 2021
  13. KAWAI A, Suzuki M, Tsukamoto K, Minato Y, et al
    Functional and Structural Characterization of Acquired Pan-Aminoglycoside Resistance 16S rRNA Methyltransferase NpmB1.
    Antimicrob Agents Chemother. 2021 Jul 26:AAC0100921. doi: 10.1128/AAC.01009.
    >> Share

  14. WANG J, Ma W, Fang Y, Liang H, et al
    Core oligosaccharide portion of lipopolysaccharide plays important roles on multiple antibiotic resistance in Escherichia coli.
    Antimicrob Agents Chemother. 2021 Jul 26:AAC0034121. doi: 10.1128/AAC.00341.
    >> Share

  15. GILL CM, Brink A, Chu CY, Coetzee J, et al
    The Phenotypic/Genotypic Profile of OXA-10-like harboring, Carbapenem-Resistant Pseudomonas aeruginosa: Using Validated Pharmacokinetic/Pharmacodynamic in vivo Models to Further Evaluate Enzyme Functionality and Clinical Implications.
    Antimicrob Agents Chemother. 2021 Jul 26:AAC0127421. doi: 10.1128/AAC.01274.
    >> Share

  16. MITCHEV N, Singh R, Allam M, Kwenda S, et al
    Antimicrobial resistance mechanisms, MLST and NG-STAR sequence types of diverse Neisseria gonorrhoeae isolates in KwaZulu-Natal, South Africa.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0075921. doi: 10.1128/AAC.00759.
    >> Share

  17. LE C, Pimentel C, Tuttobene MR, Subils T, et al
    Interplay between meropenem and human serum albumin on expression of carbapenem resistance genes and natural competence in Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0101921. doi: 10.1128/AAC.01019.
    >> Share

  18. SARDANA K, Gupta A, Sadhasivam S, Gautam RK, et al
    Checkerboard Analysis To Evaluate Synergistic Combinations of Existing Antifungal Drugs and Propylene Glycol Monocaprylate in Isolates from Recalcitrant Tinea Corporis and Cruris Patients Harboring Squalene Epoxidase Gene Mutation.
    Antimicrob Agents Chemother. 2021;65:e0032121.
    >> Share

  19. CHEW KL, Octavia S, Lai D, Lin RTP, et al
    Genomic Characterization of Klebsiella quasipneumoniae from Clinical Specimens in Singapore.
    Antimicrob Agents Chemother. 2021;65:e0041221.
    >> Share

  20. MCCREARY EK, Heil EL, Tamma PD
    New Perspectives on Antimicrobial Agents: Cefiderocol.
    Antimicrob Agents Chemother. 2021;65:e0217120.
    >> Share

  21. ZUBYK HL, Wright GD
    CrpP Is Not a Fluoroquinolone-Inactivating Enzyme.
    Antimicrob Agents Chemother. 2021;65:e0077321.
    >> Share

  22. KONG X, Tang C, Singh A, Ahmed SA, et al
    Antifungal Susceptibility and Mutations in the Squalene Epoxidase Gene in Dermatophytes of the Trichophyton mentagrophytes Species Complex.
    Antimicrob Agents Chemother. 2021;65:e0005621.
    >> Share

  23. SERRANO-LOBO J, Gomez A, Rodriguez-Sanchez B, Munoz P, et al
    Azole resistant Aspergillus fumigatus clinical isolate screening in azole-containing agar plates (EUCAST E.Def 10.1): low impact of plastic trays used and poor performance in cryptic species.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0048221. doi: 10.1128/AAC.00482.
    >> Share

  24. WESTGEEST AC, Schippers EF, Delfos NM, Ellerbroek LJ, et al
    Complicated carriage with methicillin-resistant Staphylococcus aureus (MRSA): evaluation of the effectiveness of decolonization regimens advised in the Dutch national guideline.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0025721. doi: 10.1128/AAC.00257.
    >> Share

  25. TRAUNER A, Banaei-Esfahani A, Gygli SM, Warmer P, et al
    Expression dysregulation as a mediator of fitness costs in antibiotic resistance.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0050421. doi: 10.1128/AAC.00504.
    >> Share

  26. CHEN L, Han X, Li Y, Li M, et al
    Assessment of mortality-related risk factors and effective antimicrobial regimens for the treatment of bloodstream infections caused by carbapenem-resistant Enterobacterales.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0069821. doi: 10.1128/AAC.00698.
    >> Share

  27. MAPHANGA TG, Naicker SD, Kwenda S, Munoz JF, et al
    In-vitro antifungal resistance of Candida auris isolates from bloodstream infections, South Africa.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0051721. doi: 10.1128/AAC.00517.
    >> Share

    June 2021
  28. SOMPRASONG N, Yi J, Hall CM, Webb JR, et al
    Conservation of resistance nodulation cell division efflux pump mediated antibiotic resistance in Burkholderia cepacia complex and Burkholderia pseudomallei complex species.
    Antimicrob Agents Chemother. 2021 Jun 28:AAC0092021. doi: 10.1128/AAC.00920.
    >> Share

  29. WERNGREN J, Mansjo M, Glader M, Hoffner S, et al
    Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jun 28:AAC0072021. doi: 10.1128/AAC.00720.
    >> Share

  30. FERREIRA S, Silva AL, Tomas J, Mateus C, et al
    Characterization of AreABC, an RND-type efflux system involved in antimicrobial resistance of Aliarcobacter butzleri.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0072921. doi: 10.1128/AAC.00729.
    >> Share

  31. GONZALEZ-JIMENEZ I, Garcia-Rubio R, Monzon S, Lucio J, et al
    Multi-resistance to non-azole fungicides in Aspergillus fumigatus TR34/L98H azole resistant isolates.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0064221. doi: 10.1128/AAC.00642.
    >> Share

  32. PLAUNT AJ, Rose SJ, Kang JY, Chen KJ, et al
    Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections.
    Antimicrob Agents Chemother. 2021;65:e0031621.
    >> Share

  33. KORNELSEN V, Kumar A
    Update on Multidrug Resistance Efflux Pumps in Acinetobacter spp.
    Antimicrob Agents Chemother. 2021;65:e0051421.
    >> Share

  34. ZARROUK K, Zhu X, Pham VD, Goyette N, et al
    Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet.
    Antimicrob Agents Chemother. 2021;65:e0039021.
    >> Share

  35. LIZZA BD, Betthauser KD, Ritchie DJ, Micek ST, et al
    New Perspectives on Antimicrobial Agents: Ceftolozane-Tazobactam.
    Antimicrob Agents Chemother. 2021;65:e0231820.
    >> Share

  36. GUTHRIDGE I, Smith S, Law M, Binotto E, et al
    The efficacy and safety of intravenous lincosamide therapy in methicillin-resistant Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2021 Jun 14:AAC0034321. doi: 10.1128/AAC.00343.
    >> Share

  37. TOYOTOME T, Onishi K, Sato M, Kusuya Y, et al
    Identification of novel mutations contributing to azole tolerance of Aspergillus fumigatus through in vitro exposure to tebuconazole.
    Antimicrob Agents Chemother. 2021 Jun 14:AAC0265720. doi: 10.1128/AAC.02657.
    >> Share

  38. HUANG DB, Gaukel E, Kerzee N, Borroto-Esoda K, et al
    Efficacy of Anti-Staphylococcal Lysin, LSVT-1701, in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus (MRSA).
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0050821. doi: 10.1128/AAC.00508.
    >> Share

  39. LEW C, Mishra NN, Bayer AS, Rose WE, et al
    beta-lactam-induced cell envelope adaptations, not solely enhanced daptomycin binding, underlies daptomycin-beta-lactam synergy in methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0035621. doi: 10.1128/AAC.00356.
    >> Share

  40. GUO Q, Zhang Y, Fan J, Zhang H, et al
    MAB_2355c Confers Macrolide Resistance in Mycobacterium abscessus by Ribosome Protection.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0033021. doi: 10.1128/AAC.00330.
    >> Share

  41. ABOU FAYAD AG, Haraoui LP, Sleiman A, Jaafar M, et al
    Diversity of sequence types and impact of fitness cost among carbapenem-resistant Acinetobacter baumannii isolates from Tripoli, Libya.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0027721. doi: 10.1128/AAC.00277.
    >> Share

  42. WANG C, Yin M, Zhang X, Guo Q, et al
    Identification of qnrE3 and qnrE4, new transferable quinolone resistance qnrE family genes originating from Enterobacter mori and E. asburiae, respectively.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0045621. doi: 10.1128/AAC.00456.
    >> Share

  43. LUCASSEN K, Gerson S, Xanthopoulou K, Wille J, et al
    Comparison of the A. baumannii reference strains ATCC 17978 and ATCC 19606 in antimicrobial resistance mediated by the AdeABC efflux pump.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0057021. doi: 10.1128/AAC.00570.
    >> Share

  44. BACCANI I, Antonelli A, Di Pilato V, Coppi M, et al
    Detection of poxtA2, a presumptive poxtA ancestor, in a plasmid from a linezolid-resistant Enterococcus gallinarum.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0069521. doi: 10.1128/AAC.00695.
    >> Share

  45. BHATNAGAR A, Boyd S, Sabour S, Bodnar J, et al
    Aztreonam-Avibactam Susceptibility Testing Program for Metallo-beta-lactamase-producing Enterobacterales in the Antibiotic Resistance Laboratory Network, March 2019-December 2020.
    Antimicrob Agents Chemother. 2021 Jun 1:AAC0048621. doi: 10.1128/AAC.00486.
    >> Share

    May 2021
  46. RUBIO AM, Kline EG, Jones CE, Chen L, et al
    In Vitro Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  47. SOLIMAN AM, Ramadan H, Zarad H, Sugawara Y, et al
    Coproduction of Tet(X7) Conferring High-Level Tigecycline Resistance, Fosfomycin FosA4, and Colistin Mcr-1.1 in Escherichia coli Strains from Chickens in Egypt.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  48. DESNOS-OLLIVIER M, Lortholary O, Bretagne S, Dromer F, et al
    Azole Susceptibility Profiles of More than 9,000 Clinical Yeast Isolates Belonging to 40 Common and Rare Species.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  49. MOIRANGTHEM R, Kumar K, Kaur R
    Two Functionally Redundant FK506-Binding Proteins Regulate Multidrug Resistance Gene Expression and Govern Azole Antifungal Resistance.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  50. SOBEL JD, Borroto-Esoda K, Azie N, Angulo D, et al
    In Vitro pH Activity of Ibrexafungerp Against Fluconazole-susceptible and -resistant Candida Isolates from Women with Vulvovaginal Candidiasis.
    Antimicrob Agents Chemother. 2021 May 17. pii: AAC.00562.
    >> Share

  51. CHEUNG CHP, Alorabi M, Hamilton F, Takebayashi Y, et al
    Trade-Offs Between Antibacterial Resistance and Fitness Cost in the Production of Metallo-beta-Lactamases by Enteric Bacteria Manifest as Sporadic Emergence of Carbapenem Resistance in a Clinical Setting.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02412.
    >> Share

  52. RUELENS P, de Visser JAGM
    Choice of beta-lactam resistance pathway depends critically on initial antibiotic concentration.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.00471.
    >> Share

  53. MCGUIRE RJ, Yu SC, Payne PRO, Lai AM, et al
    A Pragmatic Machine Learning Model to Predict Carbapenem Resistance.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.00063.
    >> Share

  54. KAZMIERCZAK KM, Karlowsky JA, de Jonge BLM, Stone GG, et al
    Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-nonsusceptible Enterobacterales collected as part of a Global Surveillance Program, 2012-2017.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02000.
    >> Share

  55. DARLOW CA, Docobo-Perez F, Farrington N, Johnson A, et al
    Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.00293.
    >> Share

  56. FREDERICKS LR, Lee MD, Eckert HR, Li S, et al
    Vaginal Isolates of Candida glabrata are Uniquely Susceptible to Ionophoric Killer Toxins Produced by Saccharomyces cerevisiae.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02450.
    >> Share

  57. MOK S, Roycroft E, Flanagan PR, Montgomery L, et al
    Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacterium tuberculosis isolates.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02617.
    >> Share

  58. JANICE J, Agyepong N, Owusu-Ofori A, Govinden U, et al
    Carbapenem-resistance determinants acquired through novel chromosomal integrations in XDR Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2021 May 3. pii: AAC.00289.
    >> Share

  59. LIANG T, Yang X, Li R, Yang E, et al
    Emergence of W272C Substitution in Hmg1 in a Triazole-Resistant Isolate of Aspergillus fumigatus from a Chinese Patient with Chronic Cavitary Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2021 May 3. pii: AAC.00263.
    >> Share

    April 2021
  60. LEY SD, Pillay S, Streicher EM, van der Heijden YF, et al
    Melting the Eis: non-detection of kanamycin resistance markers by routine diagnostic tests and identification of new eis-promoter variants.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.02502.
    >> Share

  61. KIM DH, Kim SY, Koh WJ, Jhun BW, et al
    In Vitro Activity of Oxazolidinone against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.02306.
    >> Share

  62. SONNENKALB L, Strohe G, Dreyer V, Andres S, et al
    Microevolution of Mycobacterium tuberculosis hetero-resistance subpopulations in a patient receiving 27 years of tuberculosis treatment in Germany.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.02520.
    >> Share

  63. CRANE JK, Alvarado CL, Sutton MD
    Role of the SOS Response in the Generation of Antibiotic Resistance In Vivo.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.00013.
    >> Share

  64. REHMAN A, Jeukens J, Levesque RC, Lamont IL, et al
    Gene-gene interactions dictate ciprofloxacin resistance in Pseudomonas aeruginosa and facilitate prediction of resistance phenotype from genome sequence data.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.02696.
    >> Share

  65. YAO D, Zhang G, Chen W, Chen J, et al
    Pyrogallol and Fluconazole Interact Synergistically In Vitro Against Candida glabrata Through an Efflux-Associated Mechanism.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.00100.
    >> Share

  66. OKOLIEGBE IN, Hijazi K, Cooper K, Ironside C, et al
    Trends of antimicrobial resistance and combination susceptibility testing of cystic fibrosis multidrug-resistant Pseudomonas aeruginosa: A ten-year update.
    Antimicrob Agents Chemother. 2021 Apr 5. pii: AAC.02483.
    >> Share

  67. POULSEN JS, Madsen AM, White JK, Nielsen JL, et al
    Physiological responses of Aspergillus niger challenged with itraconazole.
    Antimicrob Agents Chemother. 2021 Apr 5. pii: AAC.02549.
    >> Share

    March 2021
  68. GIL-MARQUES ML, Jacoby GA, Hooper DC
    Analyzing possible native functions of the quinolone resistance gene qnr in Vibrio vulnificus.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.00232.
    >> Share

  69. SICELOFF AT, Ohta N, Norman KN, Loneragan GH, et al
    Antimicrobial resistance hidden within multi-serovar Salmonella populations.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.00048.
    >> Share

  70. STEWART AG, Price EP, Schabacker K, Birikmen M, et al
    Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.00130.
    >> Share

  71. MENGUAL-CHULIA B, Alonso-Cordero A, Cano L, Del Mar Mosquera M, et al
    Surveillance of Influenza A resistance to polymerase complex inhibitors by whole genome analysis, 2016-17, 2017-18 and 2018-19 Seasons, Eastern Spain.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.02718.
    >> Share

  72. ORTIZ DE LA ROSA JM, Nordmann P, Poirel L
    Antioxidant molecules as a source of mitigation of antibiotic resistance genes dissemination.
    Antimicrob Agents Chemother. 2021 Mar 22. pii: AAC.02658.
    >> Share

  73. HIRVONEN VHA, Spencer J, van der Kamp MW
    Antimicrobial resistance conferred by OXA-48 beta-lactamases:towards a detailed mechanistic understanding.
    Antimicrob Agents Chemother. 2021 Mar 22. pii: AAC.00184.
    >> Share

  74. MASUKO A, Takata I, Fujita K, Okumura H, et al
    In Vitro and In Vivo Activities of TP0480066, a Novel Topoisomerase Inhibitor, against Neisseria gonorrhoeae.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  75. BOOT W, Schmid T, D'Este M, Guillaume O, et al
    A Hyaluronic Acid Hydrogel Loaded with Gentamicin and Vancomycin Successfully Eradicates Chronic Methicillin-Resistant Staphylococcus aureus Orthopedic Infection in a Sheep Model.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  76. NAKAMURA R, Oota M, Matsumoto S, Sato T, et al
    In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  77. MIRA PM, Ostman B, Guzman-Cole C, Sindi S, et al
    Adaptive Processes Change as Multiple Functions Evolve.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  78. DIAZ-GARCIA J, Mesquida A, Sanchez-Carrillo C, Reigadas E, et al
    Monitoring the Epidemiology and Antifungal Resistance of Yeasts Causing Fungemia in a Tertiary Care Hospital in Madrid, Spain: Any Relevant Changes in the Last 13 Years?
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  79. CAMP J, Schuster S, Vavra M, Schweigger T, et al
    Limited Multidrug Resistance Efflux Pump Overexpression among Multidrug-Resistant Escherichia coli Strains of ST131.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  80. CHENG J, Yan J, Reyna Z, Slarve M, et al
    Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  81. KARAU MJ, Schmidt-Malan SM, Mandrekar J, Lehoux D, et al
    Activity of Lysin CF-296 Alone and in Addition to Daptomycin in a Rat Model of Experimental Methicillin-Resistant Staphylococcus aureus Osteomyelitis.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.00117.
    >> Share

  82. MODLIN SJ, Marbach T, Werngren J, Mansjo M, et al
    Atypical Genetic Basis of Pyrazinamide Resistance in Mono-resistant Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.01916.
    >> Share

  83. ARDIZZONI E, Ariza E, Mulengwa D, Mpala Q, et al
    Thin layer agar-based direct phenotypic drug-susceptibility testing on sputum in Eswatini rapidly detects Mycobacterium tuberculosis growth and rifampicin resistance, otherwise missed by WHO endorsed diagnostic tests.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.02263.
    >> Share

  84. WEI Y, Sluis-Cremer N
    Mutations in the HIV-1 3'-Polypurine Tract and Integrase Strand-Transfer Inhibitor Resistance.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.02432.
    >> Share

  85. CHO HK, Karau MJ, Greenwood-Quaintance KE, Hansford KA, et al
    In Vitro Activity of Vancapticin MCC5145 against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection.
    Antimicrob Agents Chemother. 2021 Mar 8. pii: AAC.02443.
    >> Share

  86. MOHD SAZLLY LIM S, Heffernan AJ, Roberts JA, Sime FB, et al
    Semi-mechanistic PK/PD modelling of fosfomycin and sulbactam combination against carbapenem-resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021 Mar 8. pii: AAC.02472.
    >> Share

  87. ERSOY SC, Chambers HF, Proctor RA, Rosato AE, et al
    Impact of Bicarbonate on PBP2a Production, Maturation, and Functionality in Methicillin-Resistant Staphylococcus aureus (MRSA).
    Antimicrob Agents Chemother. 2021 Mar 1. pii: AAC.02621.
    >> Share

    February 2021
  88. ATTERBY C, Nykvist M, Lustig U, Andersson DI, et al
    Selection of Resistant Bacteria in Mallards Exposed to Subinhibitory Concentrations of Ciprofloxacin in Their Water Environment.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  89. FANG Y, Kirsch JR, Li L, Brooks SA, et al
    Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant Staphylococcus aureus to beta-Lactam Antibiotics.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  90. WANG G, Brunel JM, Bolla JM, Van Bambeke F, et al
    The Polyaminoisoprenyl Potentiator NV716 Revives Old Disused Antibiotics against Intracellular Forms of Infection by Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  91. LI Y, Li Y, Xiu L, Zeng Y, et al
    Typing of Neisseria Gonorrhoeae isolates in Shenzhen, China from 2014-2018 reveals the shift of genotypes associated with antimicrobial resistance.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.02311.
    >> Share

  92. FEN SHY, Tandhavanant S, Phunpang R, Ekchariyawat P, et al
    Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of beta-lactam-resistant isolates.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.02230.
    >> Share

  93. SHIRIAEV DI, Sofronova AA, Berdnikovich EA, Lukianov DA, et al
    Nybomycin inhibits both types of E. coli DNA gyrase - fluoroquinolone-sensitive and fluoroquinolone-resistant.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.00777.
    >> Share

  94. DUMKE R
    Antimicrobial resistance in clinical isolates of Ureaplasma spp. from samples in Germany.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.02342.
    >> Share

  95. LI L, Zhang M, Wang W, Xia R, et al
    Identification and characterization of two novel ISCR1-associated genes dfrA42 and dfrA43 encoding trimethoprim resistant dihydrofolate reductases.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.02010.
    >> Share

    January 2021
  96. SMITH NM, Ang A, Tan F, Macias K, et al
    Interaction of Staphylococcus aureus and Acinetobacter baumannii during in vitro beta-lactam exposure.
    Antimicrob Agents Chemother. 2021 Jan 25. pii: AAC.02414.
    >> Share

  97. OLIVER MB, Fong K, Certain L, Spivak ES, et al
    Validation of a Community-Acquired Pneumonia Score To Improve Empiric Antibiotic Selection at an Academic Medical Center.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  98. YANG J, Liu L, Feng Y, He D, et al
    Potential Mobilization of mcr-10 by an Integrative Mobile Element via Site-Specific Recombination in Cronobacter sakazakii.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  99. KHABTHANI S, Hamel M, Baron SA, Diene SM, et al
    fosM, a New Family of Fosfomycin Resistance Genes Identified in Bacterial Species Isolated from Human Microbiota.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  100. PYBUS CA, Felder-Scott C, Obuekwe V, Greenberg DE, et al
    Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  101. YIN Y, Zhang H, Zhang Y, Hu C, et al
    Fungal Zn(II)2Cys6 Transcription Factor ADS-1 Regulates Drug Efflux and Ergosterol Metabolism under Antifungal Azole Stress.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  102. MOTOS A, Li Bassi G, Pagliara F, Fernandez-Barat L, et al
    Short-Term Effects of Appropriate Empirical Antimicrobial Treatment with Ceftolozane/Tazobactam in a Swine Model of Nosocomial Pneumonia.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  103. BURNARD D, Robertson G, Henderson A, Falconer C, et al
    Burkholderia pseudomallei Clinical Isolates Are Highly Susceptible In Vitro to Cefiderocol, a Siderophore Cephalosporin.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  104. YANG X, Ye L, Chan EW, Zhang R, et al
    Characterization of an IncFIB/IncHI1B plasmid encoding efflux pump TMexCD1-TOprJ1 in a clinical tigecycline and carbapenem-resistant Klebsiella pneumoniae strain.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02340.
    >> Share

  105. CHALKER VJ, Sharratt MG, Rees C, Bell OH, et al
    Tetracycline resistance mediated by tet(M) has variable Integrative Conjugative Element composition in Mycoplasma hominis isolated in the United Kingdom from 2005-2015.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02513.
    >> Share

  106. PRATER AG, Mehta HH, Beabout K, Supandy A, et al
    Daptomycin resistance in Enterococcus faecium can be delayed by disruption of the LiaFSR stress response pathway.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.01317.
    >> Share

  107. PFALLER MA, Messer SA, Deshpande LM, Rhomberg PR, et al
    Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterisation of Candida auris Detected in a Surveillance Program.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.02031.
    >> Share

  108. CAZER CL, Westblade LF, Simon MS, Magleby R, et al
    Analysis of multidrug resistance in Staphylococcus aureus with a machine learning generated antibiogram.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.02132.
    >> Share

  109. DU W, Zhai P, Wang T, Bromley MJ, et al
    The C2H2 Transcription Factor SltA Contributes to Azole Resistance by Coregulating the Expression of the Drug Target Erg11A and the Drug Efflux Pump Mdr1 in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.01839.
    >> Share

    December 2020
  110. VALAFAR SJ
    A Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.02091.
    >> Share

  111. VIMBERG V, Cavanagh JP, Novotna M, Lenart J, et al
    Erratum for Vimberg et al., "Ribosome-Mediated Attenuation of vga(A) Expression Is Shaped by the Antibiotic Resistance Specificity of Vga(A) Protein Variants".
    Antimicrob Agents Chemother. 2020;65.
    >> Share

  112. SOMPRASONG N, Hall CM, Webb JR, Sahl JW, et al
    Burkholderia ubonensis high-level tetracycline resistance is due to efflux pump synergy involving a novel TetA(64) resistance determinant.
    Antimicrob Agents Chemother. 2020 Dec 14. pii: AAC.01767.
    >> Share

  113. CHU S, Long L, Sherif R, McCormick TS, et al
    A second generation fungerp analog SCY-247, shows potent in vitro activity against Candida auris and other clinically relevant fungal isolates.
    Antimicrob Agents Chemother. 2020 Dec 14. pii: AAC.01988.
    >> Share

  114. MARGOT N, Ram R, Rhee M, Callebaut C, et al
    Absence of Lenacapavir (GS-6207) Phenotypic Resistance in HIV Gag Cleavage Site Mutants and in Isolates with Resistance to Existing Drug Classes.
    Antimicrob Agents Chemother. 2020 Dec 7. pii: AAC.02057.
    >> Share

    November 2020
  115. SAITO S, Hayakawa K, Tsuzuki S, Ishikane M, et al
    The Impact of the Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case-Case-Control Study.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01483.
    >> Share

  116. VIJAY S, Nhung HN, Bao NLH, Thu DDA, et al
    Most-probable number based minimum duration of killing assay for determining the spectrum of rifampicin susceptibility in clinical M. tuberculosis isolates.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01439.
    >> Share

  117. ASADZADEH M, Dashti M, Ahmad S, Alfouzan W, et al
    Whole genome and targeted-amplicon sequencing of fluconazole-susceptible and -resistant Candida parapsilosis isolates from Kuwait reveals a previously undescribed N1132D polymorphism in CDR1.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01633.
    >> Share

  118. SCHUSTER S, Vavra M, Koser R, Rossen JWA, et al
    New topoisomerase inhibitors: Evaluating the potency of gepotidacin and zoliflodacin in fluoroquinolone-resistant Escherichia coli upon tolC inactivation and differentiating their efflux pump substrate nature.
    Antimicrob Agents Chemother. 2020 Nov 16. pii: AAC.01803.
    >> Share

  119. DULYAYANGKUL P, Calvopina K, Heesom KJ, Avison MB, et al
    Novel mechanisms of efflux-mediated levofloxacin resistance and reduced amikacin susceptibility in Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.01284.
    >> Share

  120. PHAM CD, Nash E, Liu H, Schmerer MW, et al
    Atypical Mutation in Neisseria gonorrhoeae 23S rRNA Associated with High-Level Azithromycin Resistance.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.00885.
    >> Share

    October 2020
  121. ARUN KB, Madhavan A, Abraham B, Balaji M, et al
    Acetylation of isoniazid - a novel mechanism of isoniazid resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.00456.
    >> Share

  122. WILLBY M, Chopra P, Lemmer D, Klein K, et al
    Molecular evaluation of fluoroquinolone resistance in serial Mycobacterium tuberculosis isolates from individuals diagnosed with multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01663.
    >> Share

  123. BUEHRLE DJ, Decker BK, Wagener MM, Adalja A, et al
    Antibiotic Consumption and Stewardship at a Hospital outside of an Early Coronavirus Disease 2019 Epicenter.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  124. BING J, Hu T, Zheng Q, Munoz JF, et al
    Experimental evolution identifies adaptive aneuploidy as a mechanism of fluconazole resistance in Candida auris.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01466.
    >> Share

  125. NAVARRO-RODRIGUEZ P, Lopez-Fernandez L, Martin-Vicente A, Guarro J, et al
    ERG11 polymorphism in voriconazole-resistant Candida tropicalis. Weak role of ERG11 expression, ergosterol content and membrane permeability.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.00325.
    >> Share

  126. BATTAGLINI D, Motos A, Bassi GL, Yang H, et al
    Efficacy of telavancin in comparison to linezolid in a porcine model of severe methicillin-resistant Staphylococcus aureus (MRSA) pneumonia.
    Antimicrob Agents Chemother. 2020 Oct 12. pii: AAC.01009.
    >> Share

  127. SAKOULAS G
    Imipenem/Cilistatin and Fosfomycin for Refractory Methicillin-Resistant Staphylococcus aureus Infection: a Novel Combination Therapy.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.02039.
    >> Share

  128. NESPOROVA K, Wyrsch ER, Valcek A, Bitar I, et al
    Escherichia coli ST457: an emerging extended-spectrum beta-lactam resistant lineage with reservoirs in wildlife and food-producing animals.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01118.
    >> Share

  129. SERRANO-LOBO J, Gomez A, Sanchez-Yebra W, Fajardo M, et al
    Azole and amphotericin B minimum inhibitory concentrations against Aspergillus fumigatus: high agreement between spectrophotometric and visual readings using the EUCAST 9.3.2 procedure.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01693.
    >> Share

  130. ZHOU YF, Liu P, Dai SH, Sun J, et al
    Activity of tigecycline or colistin in combination with zidovudine against Escherichia coli harboring tet(X) and mcr-1.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01172.
    >> Share

    September 2020
  131. CACACI M, Menchinelli G, Torelli R, Sanglard D, et al
    Fenticonazole against Fluconazole-Resistant Candida Species: New In Vitro Activity Data.
    Antimicrob Agents Chemother. 2020 Sep 28. pii: AAC.01459.
    >> Share

  132. MATSUMOTO S, Kanazawa S, Sato T, Yamano Y, et al
    Activities of Cefiderocol with Simulated Human Plasma Concentrations against Carbapenem-resistant Gram-negative Bacilli in an In Vitro Chemostat Model.
    Antimicrob Agents Chemother. 2020 Sep 8. pii: AAC.01128.
    >> Share

  133. LIM HJ, Shin JH, Kim MN, Yong D, et al
    Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common Candida Species.
    Antimicrob Agents Chemother. 2020 Sep 8. pii: AAC.00740.
    >> Share

    August 2020
  134. NELSON K, Rubio-Aparicio D, Tsivkovski R, Sun D, et al
    In Vitro Activity of the Ultra-Broad-Spectrum Beta-lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2020 Aug 31. pii: AAC.01406.
    >> Share

  135. MADUNA LD, Kock MM, van der Veer BMJW, Radebe O, et al
    Antimicrobial resistance of Neisseria gonorrhoeae isolates from high risk men in Johannesburg, South Africa.
    Antimicrob Agents Chemother. 2020 Aug 31. pii: AAC.00906.
    >> Share

  136. WANG C, Ye C, Liao L, Wang Z, et al
    Adjuvant beta-lactam therapy combined with vancomycin or daptomycin for methicillin-resistant Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.
    Antimicrob Agents Chemother. 2020 Aug 24. pii: AAC.01377.
    >> Share

  137. SABET M, Tarazi Z, Griffith DC
    In Vivo Activity of QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor, In Combination with Beta-Lactams Against Carbapenem-Resistant K. pneumoniae.
    Antimicrob Agents Chemother. 2020 Aug 24. pii: AAC.01267.
    >> Share

  138. WANG YC, Tang HL, Liao YC, Chiou CS, et al
    Erratum for Wang et al., "Cocarriage of Distinct bla KPC-2 and bla OXA-48 Plasmids in a Single Sequence Type 11 Carbapenem-Resistant Klebsiella pneumoniae Isolate".
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  139. HAGMANN SHF, Angelo KM, Huits R, Plewes K, et al
    Epidemiological, and Clinical Characteristics of International Travelers with Enteric Fever and Antibiotic Resistance Profiles of their Isolates: A GeoSentinel Analysis.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.01084.
    >> Share

  140. VIMBERG V, Cavanagh JP, Novotna M, Lenart J, et al
    Ribosome-mediated attenuation of vga(A) expression is shaped by the antibiotic resistance specificity of Vga(A) protein variants.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.00666.
    >> Share

  141. IWATA S, Tada T, Hishinuma T, Mari T, et al
    Emergence of carbapenem-resistant Providencia rettgeri and Providencia stuartti producing IMP-type metallo-beta-lactamase in Japan.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.00382.
    >> Share

  142. KIM HL, Rodriguez RD, Morris SK, Zhao S, et al
    Identification of a Novel Plasmid-Borne Gentamicin Resistance Gene in Non-typhoidal Salmonella Isolated From Retail Turkey.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.00867.
    >> Share

  143. ISNARD C, Hernandez SB, Guerin F, Joalland F, et al
    Unexpected cell wall alteration-mediated bactericidal activity of the antifungal caspofungin against vancomycin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 2020 Aug 10. pii: AAC.01261.
    >> Share

  144. GODEUX AS, Svedholm E, Lupo A, Haenni M, et al
    Scarless removal of large resistance island AbaR results in antibiotic susceptibility and increased natural transformability in Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2020 Aug 10. pii: AAC.00951.
    >> Share

  145. KIM H, Kim ES, Lee SC, Yang E, et al
    Decreased incidence of methicillin-resistant Staphylococcus aureus bacteremia in intensive care units: a 10-year clinical, microbiological, and genotypic analysis in a tertiary hospital.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.01082.
    >> Share

  146. PEIRANO G, Chen L, Kreiswirth BN, Pitout JDD, et al
    Emerging Antimicrobial Resistant High-Risk clones among Klebsiella pneumoniae: ST307 and ST147.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.01148.
    >> Share

  147. STAPLETON AE, Wagenlehner FME, Mulgirigama A, Twynholm M, et al
    E. coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection In Women: A Systematic Review.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.00862.
    >> Share

    July 2020
  148. JOHNSTON BD, Thuras P, Porter SB, Anacker M, et al
    Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Co-Resistance, and Region.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.00797.
    >> Share

  149. CAO D, Wu R, Dong S, Wang F, et al
    Azole resistance in environmental Aspergillus fumigatus isolates from China: A five-year survey from 2014 to 2018.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.00904.
    >> Share

  150. LIU PY, Lee YL, Lu MC, Shao PL, et al
    National Surveillance of Antimicrobial Susceptibility of Bacteremic Gram-Negative Bacteria with Emphasis on Community-Acquired Resistant Isolates: Report from the 2019 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).
    Antimicrob Agents Chemother. 2020 Jul 20. pii: AAC.01089.
    >> Share

  151. ARASTEHFAR A, Daneshnia F, Hilmioglu-Polat S, Fang W, et al
    First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and/or Y132F+K143R in Turkey.
    Antimicrob Agents Chemother. 2020 Jul 20. pii: AAC.01001.
    >> Share

  152. MANKTELOW CJ, Penkova E, Scott L, Matthews A, et al
    Strong environment X genotype interactions determine the fitness costs of antibiotic resistance in vitro and in an insect model of infection.
    Antimicrob Agents Chemother. 2020 Jul 13. pii: AAC.01033.
    >> Share

  153. ROUNDTREE MT, Juvvadi PR, Shwab EK, Cole DC, et al
    Aspergillus fumigatus Cyp51A and Cyp51B Proteins are Compensatory in Function and Localize Differentially in Response to Antifungals and Cell Wall Inhibitors.
    Antimicrob Agents Chemother. 2020 Jul 13. pii: AAC.00735.
    >> Share

  154. HAO M, He Y, Zhang H, Liao XP, et al
    CRISPR/Cas9-mediated carbapenemase genes and plasmids curing in carbapenem-resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2020 Jul 6. pii: AAC.00843.
    >> Share

  155. VILCHEZE C, Saranathan R, Weinrick B, Jacobs WR Jr, et al
    Characterization of large deletion mutants of Mycobacterium tuberculosis selected for isoniazid resistance.
    Antimicrob Agents Chemother. 2020 Jul 6. pii: AAC.00792.
    >> Share

    June 2020
  156. SMITH SJ, Zhao XZ, Passos DO, Lyumkis D, et al
    HIV-1 Integrase Inhibitors that are active against Drug-Resistant Integrase Mutants.
    Antimicrob Agents Chemother. 2020 Jun 29. pii: AAC.00611.
    >> Share

  157. HAO S, Abdelghany M, Lyden A, Sit R, et al
    Genomic Profiling of Evolving Daptomycin Resistance in a Patient with Recurrent Staphylococcus argenteus Sepsis.
    Antimicrob Agents Chemother. 2020 Jun 29. pii: AAC.00961.
    >> Share

  158. ZHU X, Li P, Qian C, Liu H, et al
    Prevalence of Aminoglycoside Resistance Genes and Molecular Characterization of a Novel Gene aac(3)-IIg among Clinical Isolates of Enterobacter cloacae Complex from a Chinese Teaching Hospital.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00852.
    >> Share

  159. LIM TP, Teo JQ, Goh AW, Tan SX, et al
    In vitro Pharmacodynamics of Fosfomycin Against Carbapenem-resistant Enterobacter cloacae & Klebsiella aerogenes.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00536.
    >> Share

  160. PARMAR NR, Singh R, Martin I, Perera SR, et al
    Genomic Analysis Reveals Antibiotic Susceptible Clones and Emerging Resistance in Neisseria gonorrhoeae (Saskatchewan, Canada).
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.02514.
    >> Share

  161. SAFI H, Lingaraju S, Ma S, Husain S, et al
    Rapidly-correcting Frameshift Mutations in the Mycobacterium tuberculosis orn Gene Produce Reversible Ethambutol Resistance and Small Colony Variant Morphology.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00213.
    >> Share

  162. KHALIFA HO, Arai T, Majima H, Watanabe A, et al
    Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00783.
    >> Share

  163. PAIS P, California R, Galocha M, Viana R, et al
    Candida glabrata Transcription Factor Rpn4 Mediates Fluconazole Resistance Through Regulation of Ergosterol Biosynthesis and Plasma Membrane Permeability.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00554.
    >> Share

  164. DURAO P, Ramiro RS, Pereira C, Juric J, et al
    Radial expansion facilitates the maintenance of double antibiotic resistances.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00668.
    >> Share

  165. LUTGRING JD, Balbuena R, Reese N, Gilbert SE, et al
    Antibiotic Susceptibility of NDM-Producing Enterobacterales Collected in the United States, 2017-2018.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00499.
    >> Share

  166. COHEN KA, Stott KE, Munsamy V, Manson AL, et al
    Evidence for expanding the role of streptomycin in the management of drug-resistant M. tuberculosis.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00860.
    >> Share

  167. PI R, Liu Q, Takiff HE, Gao Q, et al
    Fitness Cost and Compensatory Evolution in Levofloxacin-Resistant Mycobacterium aurum.
    Antimicrob Agents Chemother. 2020 Jun 1. pii: AAC.00224.
    >> Share

  168. NELSON K, Rubio-Aparicio D, Sun D, Dudley M, et al
    In Vitro Activity of the Ultra-Broad-Spectrum Beta-lactamase Inhibitor QPX7728 against Carbapenem-Resistant Enterobacterales (CRE) With Varying Intrinsic and Acquired Resistance Mechanisms.
    Antimicrob Agents Chemother. 2020 Jun 1. pii: AAC.00757.
    >> Share

    May 2020
  169. CAMPOS M, San Millan A, Sempere JM, Lanza VF, et al
    Simulating the Influence of Conjugative Plasmids Kinetic Values on the Multilevel Dynamics of Antimicrobial Resistance in a Membrane Computing Model.
    Antimicrob Agents Chemother. 2020 May 26. pii: AAC.00593.
    >> Share

  170. HUANG HN, Pan CY, Chan YL, Chen JY, et al
    Retraction for Huang et al., "Use of the Antimicrobial Peptide Pardaxin (GE33) To Protect against Methicillin-Resistant Staphylococcus aureus Infection in Mice with Skin Injuries".
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  171. THAPA E, Knauss HM, Colvin BA, Fischer BA, et al
    Persistence Dynamics of Antimicrobial Resistant Neisseria in the Pharynx of Rhesus Macaques.
    Antimicrob Agents Chemother. 2020 May 18. pii: AAC.02232.
    >> Share

  172. ZILBERBERG MD, Nathanson BH, Sulham K, Shorr AF, et al
    Antimicrobial susceptibility and cross-resistance patterns among common complicated urinary tract infections in US hospitals, 2013-2018.
    Antimicrob Agents Chemother. 2020 May 18. pii: AAC.00346.
    >> Share

  173. MACEDO D, Brito Devoto T, Pola S, Finquelievich JL, et al
    A novel combination of CYP51A mutations confers pan-azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2020 May 18. pii: AAC.02501.
    >> Share

  174. KEBRIAEI R, Lev K, Morrisette T, Stamper K, et al
    Bacteriophage-Antibiotic Combination Strategy: An Alternative against Methicillin-resistant Phenotypes of Staphylococcus aureus.
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00461.
    >> Share

  175. SFEIR MM
    Methicillin-resistant Staphylococcus aureus (MRSA) nasal screening: Clinical use for excluding diabetic foot infection with MRSA.
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00635.
    >> Share

  176. MERGENHAGEN KA, Croix M, Starr KE, Sellick JA, et al
    Reply to Sfeir, "Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening: Clinical Use for Excluding Diabetic Foot Infection with MRSA".
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00803.
    >> Share

  177. ADAMS SE, Lugovtsev VY, Kan A, Bovin NV, et al
    Laninamivir-Interferon-lambda1 Combination Treatment Promotes Resistance by Influenza A Virus More Rapidly Than Laninamivir Alone.
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00301.
    >> Share

  178. WILSEY HA, Burgess DR, Burgess DS
    Focusing the lens on the CAMERA concepts: Early combination beta-lactam and vancomycin therapy in methicillin-resistant Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.00360.
    >> Share

  179. SHIRAKAWA T, Sekizuka T, Kuroda M, Suzuki S, et al
    Comparative Genomic Analysis of Third Generation Cephalosporin-Resistant Escherichia coli Harboring bla CMY-2-Positive IncI1 group, IncB/O/K/Z, and IncC Plasmids Isolated from Healthy Broilers in Japan.
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.02385.
    >> Share

    April 2020
  180. SHAH SU, Xiong YQ, Abdelhady W, Iwaz J, et al
    Effect of the Lysin, Exebacase, on Cardiac Vegetation Progression in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus (MRSA) Endocarditis as Determined by Echocardiography.
    Antimicrob Agents Chemother. 2020 Apr 27. pii: AAC.00482.
    >> Share

  181. KIM D, Yoon EJ, Hong JS, Lee H, et al
    Impact of vanA-positive Enterococcus faecium exhibiting diverse susceptibility phenotypes to glycopeptides on 30-day mortality of patients with a bloodstream infection.
    Antimicrob Agents Chemother. 2020 Apr 27. pii: AAC.02180.
    >> Share

  182. RODRIGUEZ-NAVARRO J, Miro E, Brown-Jaque M, Hurtado JC, et al
    Comparison of Commensal and Clinical Isolates for Diversity of Plasmids in Escherichia coli and Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  183. COLQUE CA, Albarracin Orio AG, Feliziani S, Marvig RL, et al
    Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  184. DI J, Zhang J, Cao L, Huang TT, et al
    Hydrogen Peroxide-Mediated Oxygen Enrichment Eradicates Helicobacter pylori In Vitro and In Vivo.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  185. ENDIMIANI A, Bernasconi OJ, Budel T, Campos-Madueno EI, et al
    Whole-Genome Characterization of a Shewanella algae Strain Coharboring bla CTX-M-15 and armA Genes on a Novel IncC Plasmid.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  186. MATSUO N, Nonogaki R, Hayashi M, Wachino JI, et al
    Characterization of bla CTX-M-27/F1:A2:B20 Plasmids Harbored by Escherichia coli Sequence Type 131 Sublineage C1/H30R Isolates Spreading among Elderly Japanese in Nonacute-Care Settings.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  187. HAYASHI M, Nishiyama A, Kitamoto R, Tateishi Y, et al
    Adduct Formation of Delamanid with NAD in Mycobacteria.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  188. LIN YT, Cheng YH, Chuang C, Chou SH, et al
    Molecular and Clinical Characterization of Multidrug-Resistant and Hypervirulent Klebsiella pneumoniae Strains from Liver Abscess in Taiwan.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  189. JACOBS MR, Good CE, Hujer AM, Abdelhamed AM, et al
    ARGONAUT II Study of the In Vitro Activity of Plazomicin against Carbapenemase-Producing Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  190. PALWE S, Veeraraghavan B, Periasamy H, Khobragade K, et al
    Unorthodox Parenteral beta-Lactam and beta-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  191. ESHAGHI A, Zittermann S, Bharat A, Mulvey MR, et al
    Importation of Extensively Drug-Resistant Salmonella enterica Serovar Typhi Cases in Ontario, Canada.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  192. KIEFFER N, Poirel L, Mueller L, Mancini S, et al
    ISEcp1-Mediated Transposition Leads to Fosfomycin and Broad-Spectrum Cephalosporin Resistance in Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  193. STOESSER N, Phan HTT, Seale AC, Aiken Z, et al
    Genomic Epidemiology of Complex, Multispecies, Plasmid-Borne bla KPC Carbapenemase in Enterobacterales in the United Kingdom from 2009 to 2014.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  194. CASTANHEIRA M, Sader HS, Mendes RE, Jones RN, et al
    Activity of Plazomicin Tested against Enterobacterales Isolates Collected from U.S. Hospitals in 2016-2017: Effect of Different Breakpoint Criteria on Susceptibility Rates among Aminoglycosides.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  195. SADER HS, Carvalhaes CG, Duncan LR, Shortridge D, et al
    Antimicrobial Activity of Ceftolozane-Tazobactam and Comparators against Clinical Isolates of Haemophilus influenzae from the United States and Europe.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  196. KARKI P, Mohiuddin SG, Kavousi P, Orman MA, et al
    Investigating the Effects of Osmolytes and Environmental pH on Bacterial Persisters.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  197. KAYE KS, Boucher HW, Brown ML, Aggrey A, et al
    Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  198. SCHMERER MW, Abrams AJ, Seby S, Thomas JC 4th, et al
    Genomic Characterization of Neisseria gonorrhoeae Strains from 2016 U.S. Sentinel Surveillance Displaying Reduced Susceptibility to Azithromycin.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  199. OUESLATI S, Retailleau P, Marchini L, Berthault C, et al
    Role of Arginine 214 in the Substrate Specificity of OXA-48.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  200. PFALLER MA, Huband MD, Shortridge D, Flamm RK, et al
    Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  201. HUBAND MD, Mendes RE, Pfaller MA, Lindley JM, et al
    In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  202. MOLINA KC, Morrisette T, Miller MA, Huang V, et al
    The Emerging Role of beta-lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.00468.
    >> Share

  203. NARMANDAKH E, Tumenbayar O, Borolzoi T, Erkhembayar B, et al
    Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.00537.
    >> Share

  204. HEBERT C, Gao Y, Rahman P, Dewart C, et al
    Prediction of antibiotic susceptibility for urinary tract infection in a hospital setting.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.02236.
    >> Share

  205. ZHAO L, Yan Y, Dai Q, Li X, et al
    Development of Novel Anti-influenza Thiazolides with Relatively Broad-spectrum Antiviral Potentials.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.00222.
    >> Share

  206. WANG CH, Siu LK, Chang FY, Tsai YK, et al
    A novel deletion mutation in pmrB contributes to concurrent colistin resistance in carbapenem resistant E. coli ST 405 of clinical origin.
    Antimicrob Agents Chemother. 2020 Apr 13. pii: AAC.00220.
    >> Share

  207. ALMEIDA LM, Lebreton F, Gaca A, Bispo PM, et al
    Transferable Resistance Gene optrA in Enterococcus faecalis from Swine in Brazil.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00142.
    >> Share

  208. BROWN MM, Kwiecinski JM, Mejia Cruz L, Shahbandi A, et al
    Novel peptide from commensal Staphylococcus simulans blocks MRSA quorum sensing and protects host skin from damage.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00172.
    >> Share

    March 2020
  209. YANG T, Pan L, Wu N, Wang L, et al
    Antimicrobial resistance in clinical Ureaplasma spp. and Mycoplasma hominis and structural mechanisms underlying the quinolone resistance.
    Antimicrob Agents Chemother. 2020 Mar 30. pii: AAC.02560.
    >> Share

  210. MASI M, Pinet E, Pages JM
    Complex response of the CpxAR two-component system to beta-lactams on antibiotic resistance and envelop homeostasis in Enterobacteriaceae.
    Antimicrob Agents Chemother. 2020 Mar 30. pii: AAC.00291.
    >> Share

  211. CABRERA NL, Malek AE, Aitken SL, Arias CA, et al
    Outcomes of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis: Caution in Interpreting the Results.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  212. FELDGARDEN M, Brover V, Haft DH, Prasad AB, et al
    Erratum for Feldgarden et al., "Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates".
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  213. CASTANHEIRA M, Doyle TB, Kantro V, Mendes RE, et al
    Correction for Castanheira et al., "Meropenem-Vaborbactam Activity against Carbapenem-Resistant Enterobacterales Isolates Collected in U.S. Hospitals during 2016 to 2018".
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  214. KIM D, Lee H, Yoon EJ, Hong JS, et al
    Reply to Cabrera et al., "Outcomes of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis: Caution in Interpreting the Results".
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  215. PFALLER MA, Carvalhaes C, Messer SA, Rhomberg PR, et al
    Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018).
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  216. SHIELDS RK
    Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data?
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  217. TSIVKOVSKI R, Lomovskaya O
    Potency of Vaborbactam Is Less Affected than That of Avibactam in Strains Producing KPC-2 Mutations That Confer Resistance to Ceftazidime-Avibactam.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  218. COPPI M, Di Pilato V, Monaco F, Giani T, et al
    Ceftazidime-Avibactam Resistance Associated with Increased bla KPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  219. BONNIN RA, Jousset AB, Gauthier L, Emeraud C, et al
    First Occurrence of the OXA-198 Carbapenemase in Enterobacterales.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  220. ALAMARAT ZI, Babic J, Tran TT, Wootton SH, et al
    Long-Term Compassionate Use of Cefiderocol To Treat Chronic Osteomyelitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum-beta-Lactamase-Producing Klebsiella pneumoniae in a Pediatric Patient.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  221. LI J, Lovern M, Riccobene T, Carrothers TJ, et al
    Considerations in the Selection of Renal Dosage Adjustments for Patients with Serious Infections and Lessons Learned from the Development of Ceftazidime-Avibactam.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  222. PETRAITIENE R, Petraitis V, Kavaliauskas P, Maung BBW, et al
    Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  223. BEN JEDDOU F, Falconnet L, Luscher A, Siriwardena T, et al
    Adaptive and Mutational Responses to Peptide Dendrimer Antimicrobials in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  224. SHAW D, Singh S, Dogra S, Jayaraman J, et al
    MIC and Upper Limit of Wild-Type Distribution for 13 Antifungal Agents against a Trichophyton mentagrophytes-Trichophyton interdigitale Complex of Indian Origin.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  225. MOON SH, Kaufmann Y, Huang E
    Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against mcr-1-Mediated Polymyxin-Resistant Escherichia coli In Vivo.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  226. PUJA H, Bolard A, Nogues A, Plesiat P, et al
    The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  227. WEBB BJ, Subramanian A, Lopansri B, Goodman B, et al
    Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  228. KIEFFER N, Poirel L, Descombes MC, Nordmann P, et al
    Characterization of FosL1, a Plasmid-Encoded Fosfomycin Resistance Protein Identified in Escherichia coli.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  229. MONTERO M, Domene Ochoa S, Lopez-Causape C, VanScoy B, et al
    Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  230. FU Y, Liu D, Song H, Liu Z, et al
    Development of a Multiplex Real-Time PCR Assay for Rapid Detection of Tigecycline Resistance Gene tet(X) Variants from Bacterial, Fecal, and Environmental Samples.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  231. ARCARI G, Di Lella FM, Bibbolino G, Mengoni F, et al
    A Multispecies Cluster of VIM-1 Carbapenemase-Producing Enterobacterales Linked by a Novel, Highly Conjugative, and Broad-Host-Range IncA Plasmid Forebodes the Reemergence of VIM-1.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  232. LOGAN LK, Zhang L, Green SJ, Dorevitch S, et al
    A Pilot Study of Chicago Waterways as Reservoirs of Multidrug-Resistant Enterobacteriaceae (MDR-Ent) in a High-Risk Region for Community-Acquired MDR-Ent Infection in Children.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  233. GUDIOL C, Albasanz-Puig A, Laporte-Amargos J, Pallares N, et al
    Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  234. GRIMSEY EM, Weston N, Ricci V, Stone JW, et al
    Overexpression of RamA, Which Regulates Production of the Multidrug Resistance Efflux Pump AcrAB-TolC, Increases Mutation Rate and Influences Drug Resistance Phenotype.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  235. MCLEOD SM, Moussa SH, Hackel MA, Miller AA, et al
    In Vitro Activity of Sulbactam-Durlobactam against Acinetobacter baumannii-calcoaceticus Complex Isolates Collected Globally in 2016 and 2017.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  236. KOVACIKOVA K, Morren BM, Tas A, Albulescu IC, et al
    6'-beta-Fluoro-Homoaristeromycin and 6'-Fluoro-Homoneplanocin A Are Potent Inhibitors of Chikungunya Virus Replication through Their Direct Effect on Viral Nonstructural Protein 1.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  237. JORGENSEN SCJ, Trinh TD, Zasowski EJ, Lagnf AM, et al
    Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  238. CHATTERJEE A, Poon R, Chatterjee SS
    Stp1 loss of function promotes beta-lactam resistance in S. aureus that is independent of classical genes.
    Antimicrob Agents Chemother. 2020 Mar 16. pii: AAC.02222.
    >> Share

  239. SAMUELSEN O, Astrand OAH, Frohlich C, Heikal A, et al
    ZN148 - a modular synthetic metallo-beta-lactamase inhibitor reverses carbapenem-resistance in Gram-negative pathogens in vivo.
    Antimicrob Agents Chemother. 2020 Mar 16. pii: AAC.02415.
    >> Share

  240. LISTON SD, Whitesell L, Kapoor M, Shaw KJ, et al
    Enhanced efflux pump expression in Candida mutants results in decreased manogepix susceptibility.
    Antimicrob Agents Chemother. 2020 Mar 16. pii: AAC.00261.
    >> Share

  241. MACFADDEN DR, Coburn B, Brinda K, Corbeil A, et al
    Using Genetic Distance from Archived Samples for the Prediction of Antibiotic Resistance in Escherichia coli.
    Antimicrob Agents Chemother. 2020 Mar 9. pii: AAC.02417.
    >> Share

  242. JOHNSTON BD, Thuras P, Porter SB, Anacker M, et al
    Activity of imipenem/relebactam against carbapenem-resistant Escherichia coli isolates from the United States in relation to clonal background, resistance genes, co-resistance, and region.
    Antimicrob Agents Chemother. 2020 Mar 9. pii: AAC.02408.
    >> Share

  243. SCHWENDENER S, Dona V, Perreten V
    The novel macrolide resistance genes mef(D), msr(F) and msr(H) are present on resistance islands in Macrococcus canis, Macrococcus caseolyticus and Staphylococcus aureus.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.00160.
    >> Share

  244. CUI CY, Chen C, Liu BT, He Q, et al
    Co-occurrence of plasmid-mediated tigecycline and carbapenem resistance in Acinetobacter spp. from waterfowls and their neighboring environment.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02502.
    >> Share

  245. ENKIRCH T, Werngren J, Groenheit R, Alm E, et al
    Systematic review of whole genome sequencing data to predict phenotypic drug resistance and susceptibility in Swedish Mycobacterium tuberculosis isolates 2016-2018.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02550.
    >> Share

  246. SINGH KV, Arias CA, Murray BE
    Tedizolid as step-down therapy following daptomycin versus continuation of daptomycin against enterococci and Staphylococcus aureus (MRSA/VRSA) in a rat endocarditis model.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02303.
    >> Share

    February 2020
  247. JAHANBAKHSH S, Singh NB, Yim J, Kebriaei R, et al
    Impact of Daptomycin Dose Exposure Alone or in Combination with beta- lactams or Rifampin against Vancomycin-Resistant Enterococci (VRE) in an In vitro Biofilm Model.
    Antimicrob Agents Chemother. 2020 Feb 24. pii: AAC.02074.
    >> Share

  248. ACKLEY R, Roshdy D, Meredith J, Minor S, et al
    Meropenem/Vaborbactam versus Ceftazidime/Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections.
    Antimicrob Agents Chemother. 2020 Feb 24. pii: AAC.02313.
    >> Share

  249. LI Q, Zhao P, Li L, Zhao H, et al
    Engineering a CRISPR Interference System To Repress a Class 1 Integron in Escherichia coli.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  250. SIOPI M, Tarpatzi A, Kalogeropoulou E, Damianidou S, et al
    Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  251. ZIMMERMAN SM, Lafontaine AJ, Herrera CM, Mclean AB, et al
    A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  252. MORRISSEY I, Olesky M, Hawser S, Lob SH, et al
    In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  253. LIU Y, Tan Y, Islam MM, Cao Y, et al
    Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  254. SONNABEND MS, Klein K, Beier S, Angelov A, et al
    Identification of Drug Resistance Determinants in a Clinical Isolate of Pseudomonas aeruginosa by High-Density Transposon Mutagenesis.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  255. HAMDI AM, Fida M, Deml SM, Abu Saleh OM, et al
    Retrospective Analysis of Antimicrobial Susceptibility Profiles of Nocardia Species from a Tertiary Hospital and Reference Laboratory, 2011 to 2017.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  256. RAMIREZ S, Fernandez-Antunez C, Mikkelsen LS, Pedersen J, et al
    Cell Culture Studies of the Efficacy and Barrier to Resistance of Sofosbuvir-Velpatasvir and Glecaprevir-Pibrentasvir against Hepatitis C Virus Genotypes 2a, 2b, and 2c.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  257. MACK AR, Barnes MD, Taracila MA, Hujer AM, et al
    A Standard Numbering Scheme for Class C beta-Lactamases.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  258. IDOWU T, Zhanel GG, Schweizer F
    A Dimer, but Not Monomer, of Tobramycin Potentiates Ceftolozane against Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa and Delays Resistance Development.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  259. MONTOYA MC, Beattie S, Alden KM, Krysan DJ, et al
    Derivatives of the Antimalarial Drug Mefloquine Are Broad-Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  260. COLEMAN SR, Blimkie T, Falsafi R, Hancock REW, et al
    Multidrug Adaptive Resistance of Pseudomonas aeruginosa Swarming Cells.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  261. MCCORMICK KD, Penrose KJ, Brumme CJ, Harrigan R, et al
    Discordance between Etravirine Phenotype and Genotype-based Predicted Phenotype for Subtype C HIV-1 from First-line Antiretroviral Therapy Failures in South Africa.
    Antimicrob Agents Chemother. 2020 Feb 18. pii: AAC.02101.
    >> Share

  262. CARVAJAL LP, Rincon S, Echeverri AM, Porras J, et al
    Novel Insights Into The Classification of Staphylococcal beta-Lactamases In Relation To The Cefazolin Inoculum Effect.
    Antimicrob Agents Chemother. 2020 Feb 18. pii: AAC.02511.
    >> Share

  263. ERSOY SC, Otmishi M, Milan VT, Li L, et al
    Scope and Predictive Genetic/Phenotypic Signatures of 'Bicarbonate [NaHCO3]-Responsiveness' and beta-Lactam Sensitization Among Methicillin-Resistant Staphylococcus aureus (MRSA).
    Antimicrob Agents Chemother. 2020 Feb 10. pii: AAC.02445.
    >> Share

  264. CHOI S, Moon SM, Park SJ, Lee SC, et al
    Antagonistic effect of colistin on vancomycin activity against methicillin-resistant Staphylococcus aureus in in vitro and in vivo studies.
    Antimicrob Agents Chemother. 2020 Feb 10. pii: AAC.01925.
    >> Share

  265. DJORIC D, Little JL, Kristich CJ
    Multiple low-reactivity class B penicillin-binding proteins are required for cephalosporin resistance in enterococci.
    Antimicrob Agents Chemother. 2020 Feb 10. pii: AAC.02273.
    >> Share

  266. GENGENBACHER M, Zimmerman MD, Sarathy JP, Kaya F, et al
    Tissue distribution of doxycycline in animal models of tuberculosis.
    Antimicrob Agents Chemother. 2020 Feb 10. pii: AAC.02479.
    >> Share

  267. ZARROUK K, Pham VD, Piret J, Shi R, et al
    Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.01910.
    >> Share

  268. CARVALHAES CG, Sader HS, Flamm RK, Streit JM, et al
    Assessment of Tedizolid In Vitro Activity and Resistance Mechanisms against a Collection of Enterococcus spp. Causing Invasive Infections Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from United States and European Medical
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.00175.
    >> Share

  269. ARAI T, Majima H, Watanabe A, Kamei K, et al
    A simple method to detect point mutations in Aspergillus fumigatus cyp51A gene using a Surveyor Nuclease assay.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.02271.
    >> Share

  270. HELLEBERG M, Jorgensen KM, Hare RK, Datcu R, et al
    Rezafungin In Vitro Activity against Contemporary Clinical Nordic Candida Isolates and Candida auris Determined by the EUCAST Reference Method.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.02438.
    >> Share

    January 2020
  271. MERGENHAGEN KA, Croix M, Starr KE, Sellick JA, et al
    The utility of methicillin-resistant Staphylococcus aureus nares screening for patients with a diabetic foot infection.
    Antimicrob Agents Chemother. 2020 Jan 27. pii: AAC.02213.
    >> Share

  272. EKKELENKAMP MB, Canton R, Diez-Aguilar M, Tunney MM, et al
    Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  273. DJUKOVIC A, Gonzalez-Barbera EM, Sanz J, Artacho A, et al
    High Heterogeneity of Multidrug-Resistant Enterobacteriaceae Fecal Levels in Hospitalized Patients Is Partially Driven by Intravenous beta-Lactams.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  274. KOLPEN M, Jensen PO, Qvist T, Kragh KN, et al
    Biofilms of Mycobacterium abscessus Complex Can Be Sensitized to Antibiotics by Disaggregation and Oxygenation.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  275. FLEISCHMANN WA, Greenwood-Quaintance KE, Patel R
    In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  276. CALVOPINA K, Dulyayangkul P, Avison MB
    Mutations in Ribosomal Protein RplA or Treatment with Ribosomal Acting Antibiotics Activates Production of Aminoglycoside Efflux Pump SmeYZ in Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  277. POIREL L, Palmieri M, Brilhante M, Masseron A, et al
    PFM-Like Enzymes Are a Novel Family of Subclass B2 Metallo-beta-Lactamases from Pseudomonas synxantha Belonging to the Pseudomonas fluorescens Complex.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  278. SONG H, Liu D, Li R, Fu Y, et al
    Polymorphism Existence of Mobile Tigecycline Resistance Gene tet(X4) in Escherichia coli.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  279. RICHARD M, Gutierrez AV, Kremer L
    Dissecting erm(41)-Mediated Macrolide-Inducible Resistance in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  280. SUN Q, Xiong K, Yuan Y, Yu J, et al
    Inhibiting Fungal Echinocandin Resistance by Small-Molecule Disruption of Geranylgeranyltransferase Type I Activity.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  281. FANG LX, Jiang Q, Deng GH, He B, et al
    Diverse and Flexible Transmission of fosA3 Associated with Heterogeneous Multidrug Resistance Regions in Salmonella enterica Serovar Typhimurium and Indiana Isolates.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  282. MARGOT N, Ram R, Abram M, Haubrich R, et al
    Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog Mutations and M184V.
    Antimicrob Agents Chemother. 2020 Jan 27. pii: AAC.02557.
    >> Share

  283. WATERER G, Lord J, Hofmann T, Jouhikainen T, et al
    A Phase I, dose-escalating study of safety and pharmacokinetics of inhaled dry powder vancomycin (AeroVanc) in volunteers and patients with cystic fibrosis: a new approach to therapy for methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2020 Jan 21. pii: AAC.01776.
    >> Share

  284. MILLER CR, Dey S, Smolenski PD, Kulkarni PS, et al
    Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus With Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01593.
    >> Share

  285. BIAGI M, Shajee A, Vialichka A, Jurkovic M, et al
    Activity of imipenem-relebactam and meropenem-vaborbactam against carbapenem-resistant SME-producing Serratia marcescens.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.02255.
    >> Share

  286. ROTONDO CM, Sychantha D, Koteva K, Wright GD, et al
    Suppression of beta-Lactam Resistance by Aspergillomarasmine A is Influenced by Both the Metallo-beta-Lactamase Target and the Antibiotic Partner.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01386.
    >> Share

  287. RICARDO E, Grenouillet F, Miranda IM, Silva RM, et al
    Mechanisms of acquired in vivo and in vitro resistance to voriconazole by Candida krusei following exposure to suboptimal drug concentration.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01651.
    >> Share

  288. O'BRIEN B, Chaturvedi S, Chaturvedi V
    In vitro Evaluation of Antifungal Drug Combinations against Multidrug-resistant Candida auris isolates from New York Outbreak.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.02195.
    >> Share

  289. ALLAN DS, Del Carmen Parquet M, Savage KA, Holbein BE, et al
    Iron sequestrant DIBI, potential alternative for nares decolonization of MRSA Staphylococcus aureus, is anti-infective and inhibitory for mupirocin resistant isolates.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.02353.
    >> Share

    December 2019
  290. KOBRAS CM, Piepenbreier H, Emenegger J, Sim A, et al
    BceAB-type antibiotic resistance transporters appear to act by target protection of cell wall synthesis.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02241.
    >> Share

  291. DEMCZUK W, Martin I, Sawatzky P, Allen V, et al
    Equations to predict antimicrobial minimum inhibitory concentrations in Neisseria gonorrhoeae using molecular antimicrobial resistance determinants.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02005.
    >> Share

  292. BJUGARD NYBERG H, Draper HR, Garcia-Prats AJ, Thee S, et al
    Population pharmacokinetics and dosing of ethionamide in children with tuberculosis.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.01984.
    >> Share

  293. PONTES L, Beraquet CAG, Arai T, Pigolli GL, et al
    Aspergillus fumigatus clinical isolates carrying CYP51A TR34/L98H/S297T/F495I mutation detected after 4 years retrospective azole resistance screening test in Brazil.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02059.
    >> Share

  294. BRYSON D, Hettle AG, Boraston AB, Hobbs JK, et al
    Clinical Mutations that Partially Activate the Stringent Response Confer Multi-Drug Tolerance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02103.
    >> Share

  295. QIN T
    Reply to Edelstein, "Azithromycin Phenotypic versus Clinical Resistance".
    Antimicrob Agents Chemother. 2019;64.
    >> Share

  296. EDELSTEIN PH
    Azithromycin Phenotypic versus Clinical Resistance.
    Antimicrob Agents Chemother. 2019;64.
    >> Share

  297. ASLAM S, Schooley RT
    What's Old Is New Again: Bacteriophage Therapy in the 21st Century.
    Antimicrob Agents Chemother. 2019;64.
    >> Share

  298. ROSE WE, Bienvenida AM, Xiong YQ, Chambers HF, et al
    Ability of Bicarbonate Supplementation to Sensitize Selected Methicillin-Resistant Staphylococcus aureus (MRSA) Strains to beta-Lactam Antibiotics in an Ex Vivo Simulated Endocardial Vegetation Model.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.02072.
    >> Share

  299. AOKI S, Nakase K, Nakaminami H, Wajima T, et al
    Transferable multidrug resistance plasmid carrying a novel macrolides-clindamycin resistance gene erm(50) in Cutibacterium acnes.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.01810.
    >> Share

  300. AGUILERA-ALONSO D, Escosa-Garcia L, Saavedra-Lozano J, Cercenado E, et al
    Carbapenem-Resistant Gram-Negative Infections in Children.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.02183.
    >> Share

  301. MULLANE EM, Avery LM, Nicolau DP
    Comparative evaluation of the in vitro activities of WCK 5222 (cefepime/zidebactam) and combination antibiotic therapies against carbapenem-resistant Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.01669.
    >> Share

  302. DELLIERE S, Verdurme L, Bigot J, Dannaoui E, et al
    Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B Against azole-susceptible and -resistant Aspergillus section Fumigati clinical isolates.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.01597.
    >> Share

  303. WIEDERHOLD NP, Najvar LK, Jaramillo R, Olivo M, et al
    The Novel Arylamidine T-2307 Demonstrates In vitro and In vivo Activity Against Candida auris.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.02198.
    >> Share

  304. TSOLAKI V, Mantzarlis K, Mpakalis A, Malli E, et al
    Ceftazidime-avibactam to treat life-threatening infections from carbapenem resistant pathogens in critically ill mechanically ventilated patients.
    Antimicrob Agents Chemother. 2019 Dec 9. pii: AAC.02320.
    >> Share

    November 2019
  305. RECIO R, Mancheno M, Viedma E, Villa J, et al
    Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa: Impact of Antimicrobial Resistance and Bacterial Virulence.
    Antimicrob Agents Chemother. 2019 Nov 25. pii: AAC.01759.
    >> Share

  306. ALBAC S, Labrousse D, Hayez D, Anzala N, et al
    Activity of different anti-staphylococcal therapies, alone or combined, in a rat model of methicillin-resistant Staphylococcus epidermidis osteitis without implant.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.01865.
    >> Share

  307. GHOSH D, Veeraraghavan B, Elangovan R, Vivekanandan P, et al
    Antibiotic resistance and epigenetics: more to it than meets the eye.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.02225.
    >> Share

  308. FRAILE-RIBOT P, Zamorano L, Orellana R, Barrio-Tofino ED, et al
    Activity of imipenem/relebactam against a large collection of Pseudomonas aeruginosa clinical isolates and isogenic beta-lactam resistant mutants.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.02165.
    >> Share

  309. CHEN M, Zhang C, Zhang X, Chen M, et al
    Meningococcal quinolone resistance originated from several commensal Neisseria species.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.01494.
    >> Share

  310. HONDA H, Sato T, Shinagawa M, Fukushima Y, et al
    In vitro Derivation of Fluoroquinolone-resistant Mutants from Multiple Lineages of Haemophilus influenzae and Identification of Mutations Associated with Fluoroquinolone Resistance.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.01500.
    >> Share

  311. FAN H, Chen Y, Duan L, Zhao J, et al
    Characterization of azole resistance in Aspergillus fumigatus from potting soil samples in a Chinese hospital:comparison of two typing methods.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.01578.
    >> Share

  312. WATSON A, Sauve K, Cassino C, Schuch R, et al
    Exebacase demonstrates in vitro synergy with a broad range of antibiotics against both methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01885.
    >> Share

  313. CASTANHEIRA M, Doyle TB, Kantro V, Mendes RE, et al
    Meropenem-Vaborbactam Activity against Carbapenem-Resistant Enterobacterales Isolates Collected in U.S. Hospitals During 2016-2018.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01951.
    >> Share

  314. THALSO-MADSEN I, Torrubia FR, Xu L, Petersen A, et al
    The Sle1 Cell Wall Amidase is essential for beta-Lactam Resistance in Community Acquired Methicillin Resistant Staphylococcus aureus USA300.
    Antimicrob Agents Chemother. 2019 Nov 4. pii: AAC.01931.
    >> Share

  315. KAYE KS, Patel T, Drusano G
    Is Daptomycin plus Ceftaroline the Way To Go for Methicillin-Resistant Staphylococcus aureus Bacteremia?
    Antimicrob Agents Chemother. 2019;63.
    >> Share

    October 2019
  316. LOOSE M, Link I, Naber KG, Wagenlehner FME, et al
    Carbapenem-containing combination antibiotic therapy against carbapenem-resistant uropathogenic Enterobacteriaceae.
    Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01839.
    >> Share

  317. IOVLEVA A, Mettus RT, McElheny CL, Griffifth MP, et al
    High-level carbapenem resistance triggered by ertapenem therapy in OXA-232-producing Raoultella ornithinolytica.
    Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01335.
    >> Share

  318. YADAV R, Bergen PJ, Rogers KE, Kirkpatrick CMJ, et al
    Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients.
    Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01679.
    >> Share

  319. KANG CK, Song KH, Kim SE, Kim ES, et al
    Durations of Staphylococcus aureus bacteremia according to different phenotypes and a new concept of persistent bacteremia: a prospective cohort study.
    Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01656.
    >> Share

  320. CEBALLOS S, Kim C, Qian Y, Mobashery S, et al
    Susceptibility of methicillin-resistant Staphylococcus aureus to five quinazolinone antibacterials.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01344.
    >> Share

  321. GUITOR AK, Raphenya AR, Klunk J, Kuch M, et al
    Capturing the Resistome: A targeted capture method to reveal antibiotic resistance determinants in metagenomes.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01324.
    >> Share

  322. KUIPERS S, Ruth MM, Mientjes M, de Sevaux RGL, et al
    Successful treatment of chronic relapsing urinary tract infection with bacteriophages in a renal transplant recipient - a Dutch case report.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01281.
    >> Share

  323. FISCHER K, Nguyen K, LiWang PJ
    Griffithsin retains anti-HIV-1 potency with changes in gp120 glycosylation and complements broadly neutralizing antibodies PGT121 and PGT126.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01084.
    >> Share

  324. KAPOOR M, Moloney M, Soltow QA, Pillar CM, et al
    Evaluation of Resistance Development to the Gwt1 inhibitor Manogepix (APX001A) in Candida Species.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01387.
    >> Share

  325. CLANCY CJ, Nguyen MH
    Estimating the size of the United States market for new antibiotics with activity against carbapenem-resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01733.
    >> Share

    September 2019
  326. LOPES AA, Yoshii Y, Yamada S, Nagakura M, et al
    Roles of lytic transglycosylases in biofilm formation and beta-lactam resistance in methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Sep 30. pii: AAC.01277.
    >> Share

  327. YU X, Zheng B, Zhang J, Xu H, et al
    Comprehensive Genome Analysis of Carbapenem-Resistant Raoultella spp. strains, an Emerging Multidrug-Resistant Bacteria in Hospitals.
    Antimicrob Agents Chemother. 2019 Sep 30. pii: AAC.01367.
    >> Share

  328. SIMON MS, Sfeir MM, Calfee DP, Satlin MJ, et al
    Cost-effectiveness of ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae bacteremia and pneumonia.
    Antimicrob Agents Chemother. 2019 Sep 23. pii: AAC.00897.
    >> Share

  329. WATKINS RR, Holubar M, David MZ
    Antimicrobial resistance in methicillin-resistant Staphylococcus aureus to newer antimicrobial agents.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01216.
    >> Share

  330. KAWALEK A, Modrzejewska M, Zieniuk B, Bartosik AA, et al
    Interaction of ArmZ with the DNA-binding domain of MexZ induces expression of mexXY multidrug efflux pump genes and antimicrobial resistance in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01199.
    >> Share

  331. RODRIGUES M, McBride SW, Hullahalli K, Palmer KL, et al
    Conjugative delivery of CRISPR-Cas9 for the selective depletion of antibiotic-resistant enterococci.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01454.
    >> Share

  332. WEBB HE, Tagg KA, Chen JC, Kim J, et al
    Novel quinolone resistance determinant, qepA8, in Shigella flexneri isolated in the United States, 2016.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01458.
    >> Share

  333. KIM D, Hong JS, Yoon EJ, Lee H, et al
    Toxic shock syndrome toxin 1-producing methicillin-resistant Staphylococcus aureus of clonal complex 5, the New York/Japan epidemic clone, causing a high early mortality rate in patients with bloodstream infections.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.01362.
    >> Share

  334. YUI ETO K, Firth N, Davis AM, Kwong SM, et al
    Evolution of a 72-kb cointegrant, conjugative multiresistance plasmid from early community-associated methicillin-resistant Staphylococcus aureus isolates.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.01560.
    >> Share

  335. LABORDA P, Alcalde-Rico M, Blanco P, Martinez JL, et al
    Novel inducers of the expression of multidrug efflux pumps that trigger Pseudomonas aeruginosa transient antibiotic resistance.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.01095.
    >> Share

  336. RICHARDS JP, Cai W, Zill NA, Zhang W, et al
    Adaptation of Mycobacterium tuberculosis to biofilm growth is genetically linked to drug tolerance.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.01213.
    >> Share

  337. NUNNALLY NS, Etienne KA, Angulo D, Lockhart SR, et al
    In vitro activity of ibrexafungerp, a novel glucan synthase inhibitor against Candida glabrata isolates with FKS mutations.
    Antimicrob Agents Chemother. 2019 Sep 3. pii: AAC.01692.
    >> Share

  338. LAMOTH F, Kontoyiannis DP
    Therapeutic challenges of non-Aspergillus invasive mold infections in immunosuppressed patients.
    Antimicrob Agents Chemother. 2019 Sep 3. pii: AAC.01244.
    >> Share

    August 2019
  339. HAN JH, Lapp Z, Bushman F, Lautenbach E, et al
    Whole Genome Sequencing to Identify Drivers of Carbapenem-Resistant Klebsiella pneumoniae Transmission Within and Between Regional Long-Term Acute Care Hospitals.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.01622.
    >> Share

  340. TALBOT JJ, Frisvad JC, Meis JF, Hagen F, et al
    Cyp51A mutations, Extrolite Profiles and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.00632.
    >> Share

  341. KISHIMOTO T, Ishida W, Fukuda K, Nakajima I, et al
    Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.01088.
    >> Share

  342. FELDGARDEN M, Brover V, Haft DH, Prasad AB, et al
    Validating the NCBI AMRFinder Tool and Resistance Gene Database Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of NARMS Isolates.
    Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.00483.
    >> Share

  343. WIEDERHOLD NP, Najvar LK, Shaw KJ, Jaramillo R, et al
    Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis.
    Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.01120.
    >> Share

  344. JIA X, Ren H, Nie X, Li Y, et al
    Antibiotic resistance and azithromycin resistance mechanism of Legionella pneumophila serogroup 1 in China.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.00768.
    >> Share

  345. NAKAMURA I, Ohsumi K, Takeda S, Katsumata K, et al
    ASP2397, a novel natural compound that exhibits rapid and potent fungicidal activity against Aspergillus species through a specific transporter.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.02689.
    >> Share

  346. WIEDERHOLD NP, Najvar LK, Jaramillo R, Olivo M, et al
    Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.01165.
    >> Share

  347. MARIMUTHU K, Ng OT, Cherng BPZ, Fong RKC, et al
    Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (NCPCRE) and Carbapenemase-Producing Enterobacteriaceae (CPE).
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.00845.
    >> Share

  348. BOLARD A, Schniederjans M, Haussler S, Triponney P, et al
    Production of norspermidine contributes to aminoglycoside resistance in pmrAB mutants of Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01044.
    >> Share

  349. VAZQUEZ-UCHA JC, Martinez-Guitian M, Maneiro M, Conde-Perez K, et al
    Therapeutic efficacy of LN-1-255 in combination with imipenem in severe infection caused by carbapenem-resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01092.
    >> Share

  350. WILLIAMSON DA, Fairley CK, Howden BP, Chen MY, et al
    Trends and risk factors for antimicrobial-resistant Neisseria gonorrhoeae, Melbourne, Australia, 2007 - 2018.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01221.
    >> Share

  351. NISHIMOTO AT, Whaley SG, Wiederhold NP, Zhang Q, et al
    Impact of the major Candida glabrata triazole resistance determinants on the activity of the novel investigational tetrazoles VT-1598 and VT-1161.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01304.
    >> Share

  352. WRIGHT WF, Bejou N, Shields RK, Marr K, et al
    Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for FKS-Associated Echinocandin Resistance in Candida glabrata Septic Arthritis and Osteomyelitis.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

    July 2019
  353. KARAU MJ, Schmidt-Malan SM, Yan Q, Greenwood-Quaintance KE, et al
    Exebacase in Addition to Daptomycin is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.01235.
    >> Share

  354. XU Q, Chen T, Yan B, Zhang L, et al
    Dual role of gnaA in antibiotic resistance and virulence in Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.00694.
    >> Share

  355. PRATER AG, Mehta HH, Kosgei AJ, Miller WR, et al
    Environment Shapes the Accessible Daptomycin Resistance Mechanisms in Enterococcus faecium.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00790.
    >> Share

  356. KORYCKA-MACHALA M, Viljoen A, Pawelczyk J, Borowka P, et al
    1H-benzo[d]imidazole derivatives affect MmpL3 in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00441.
    >> Share

  357. G C B, Sahukhal GS, Elasri MO
    Role of the msaABCR operon in cell wall biosynthesis, autolysis, integrity, and antibiotic resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.00680.
    >> Share

  358. AHMED MN, Porse A, Abdelsamad A, Sommer M, et al
    Lack of the major multifunctional catalase KatA in P.aeruginosa accelerates evolution of antibiotic resistance in ciprofloxacin-treated biofilms.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.00766.
    >> Share

  359. DONG N, Sun Q, Huang Y, Shu L, et al
    Evolution of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae by acquisition of bla VIM-1-bearing plasmid.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.01056.
    >> Share

  360. YOUSFI H, Cassagne C, Ranque S, Rolain JM, et al
    Repurposing of ribavirin as an adjunct therapy against invasive Candida strains: In vitro study.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.00263.
    >> Share

  361. RIVERO-MENENDEZ O, Soto-Debran JC, Medina N, Lucio J, et al
    Molecular identification, antifungal susceptibility testing and mechanisms of azole resistance in Aspergillus spp. received within a surveillance program on antifungal resistance in Spain.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00865.
    >> Share

  362. VATANSHENASSAN M, Arastehfar A, Boekhout T, Berman J, et al
    Rapid antifungal susceptibility testing of Candida glabrata isolates against anidulafungin from positive blood culture by MBT ASTRA.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00554.
    >> Share

  363. DAHESH S, Wong B, Nizet V, Sakoulas G, et al
    Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  364. CANVER MC, Satlin MJ, Westblade LF, Kreiswirth BN, et al
    Activity of imipenem-relebactam and comparator agents against genetically characterized isolates of carbapenem-resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00672.
    >> Share

  365. GHODOUSI A, Rizvi AH, Baloch AQ, Ghafoor A, et al
    Acquisition of cross-resistance to Bedaquiline and Clofazimine following treatment for Tuberculosis in Pakistan.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00915.
    >> Share

  366. LI Q, Cheng J, Wu Y, Wang Z, et al
    Effects of Delayed Antibiotic Therapy on Outcomes in Children with Streptococcus pneumoniae Sepsis.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00623.
    >> Share

    June 2019
  367. YAMASHITA Y, Nagaoka K, Kimura H, Suzuki M, et al
    Efficacy of azithromycin in a mouse pneumonia model against hospital-acquired methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00149.
    >> Share

  368. PAULSHUS E, Thorell K, Guzman-Otazo J, Joffre E, et al
    Repeated isolation of ESBL positive Escherichia coli ST648 and ST131 from community wastewater - are sewage systems important sources of emerging clones of antibiotic resistant bacteria?
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00823.
    >> Share

  369. LAM SW, Athans V
    Clinical and Microbiological Outcomes in Obese Patients Receiving Colistin for Carbapenem-Resistant Gram-negative Bloodstream Infection.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00531.
    >> Share

  370. NAKANO S, Fujisawa T, Ito Y, Chang B, et al
    Penicillin-binding protein typing, antibiotic resistance gene identification and molecular phylogenetic analysis of meropenem-resistant Streptococcus pneumoniae serotype 19A-CC3111 strains in Japan.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00711.
    >> Share

  371. SEWELL TR, Zhang Y, Brackin AP, Shelton JMG, et al
    Elevated prevalence of azole resistant Aspergillus fumigatus in urban versus rural environments in the United Kingdom.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00548.
    >> Share

  372. LEE H, Boyle-Vavra S, Ren J, Jarusiewicz J, et al
    Identification of small molecules exhibiting oxacillin synergy through a novel assay for inhibition of vraTSR expression in methicillin resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.02593.
    >> Share

  373. PARQUET MDC, Savage KA, Allan DS, Ang MTC, et al
    Antibiotic resistant Acinetobacter baumannii is susceptible to the novel iron-sequestering anti-infective DIBI in vitro and in experimental pneumonia in mice.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00855.
    >> Share

  374. DOLEJSKA M, Literak I
    Wildlife is overlooked in the epidemiology of medically important antimicrobial resistant bacteria.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.01167.
    >> Share

  375. REHBERG N, Omeje E, Ebada SS, van Geelen L, et al
    3-O-Methyl-alkylgallates inhibit fatty acid desaturation in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00136.
    >> Share

  376. PERICAS JM, Nathavitharana R, Garcia-de-la-Maria C, Falces C, et al
    Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00516.
    >> Share

  377. KIM DH, Jhun BW, Moon SM, Kim SY, et al
    In Vitro Activity of Bedaquiline and Delamanid Against Nontuberculous Mycobacteria Including Macrolide-Resistant Clinical Isolates.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00665.
    >> Share

  378. BARNES MD, Taracila MA, Good CE, Bajaksouzian S, et al
    Nacubactam enhances meropenem activity against carbapenem-resistant Klebsiella pneumoniae producing Klebsiella pneumoniae carbapenemases (KPC).
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00432.
    >> Share

  379. VINUE L, Sater MRA, Herriott I, Huntley MH, et al
    Multiple copies of qnrA1 on an Inc A/C2 plasmid explain enhanced quinolone resistance in an Escherichia coli mutant.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00718.
    >> Share

  380. HIND CK, Dowson CG, Sutton JM, Jackson T, et al
    Evaluation of a library of FDA-approved drugs for their ability to potentiate antibiotics against multidrug resistant Gram-negative pathogens.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00769.
    >> Share

  381. BARNARD JP, Huber KD, Sluis-Cremer N
    NNRTI Hyper-Susceptibility and Resistance: Mutational Analysis of Residue 181 in HIV-1 Reverse Transcriptase.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00676.
    >> Share

    May 2019
  382. WACHINO JI, Jin W, Kimura K, Arakawa Y, et al
    Intercellular Transfer of Chromosomal Antimicrobial-resistance Genes between Acinetobacter baumannii Mediated by Prophages.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00334.
    >> Share

  383. WADSWORTH CB, Sater MRA, Bhattacharyya RP, Grad YH, et al
    Impact of species diversity on the design of RNA-based diagnostics for antibiotic resistance in Neisseria gonorrhoeae.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00549.
    >> Share

  384. TAMMA PD, Kazmi A, Bergman Y, Goodman KE, et al
    The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during the Hospital Stay.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00757.
    >> Share

  385. TOHYA M, Tada T, Watanabe S, Kuwahara-Arai K, et al
    Emergence of carbapenem-resistant Pseudomonas asiatica producing NDM-1 and VIM-2 metallo-beta-lactamases in Myanmar.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00475.
    >> Share

  386. CHOUDHARY DK, Bhakt P, Kaur R
    An essential role for the PI(3,5)P2 synthesis complex in caspofungin tolerance and virulence in Candida glabrata.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00886.
    >> Share

  387. THEYS K, Libin PJK, Van Laethem K, Abecasis AB, et al
    An evolutionary-based approach to quantify the genetic barrier to drug resistance in fast-evolving viruses: an application to HIV-1 subtypes and integrase inhibitors.
    Antimicrob Agents Chemother. 2019 May 20. pii: AAC.00539.
    >> Share

  388. LIU D, Liu W, Lv Z, Xia J, et al
    Emerging erm(B)-mediated macrolide resistance associated with novel MDRGIs in Campylobacter.
    Antimicrob Agents Chemother. 2019 May 13. pii: AAC.00153.
    >> Share

  389. TAKAMATSU Y, Aoki M, Bulut H, Das D, et al
    Novel protease inhibitors containing C-5-modified bis-THF and aminobenzothiazole as P2 and P2' ligands that exert potent antiviral activity against highly multidrug-resistant HIV-1 with high genetic barrier against the emergence of drug resistance.
    Antimicrob Agents Chemother. 2019 May 13. pii: AAC.00372.
    >> Share

  390. AMANO M, Salcedo-Gomez PM, Yedidi RS, Zhao R, et al
    Novel Central Nervous System (CNS)-Targeting Protease Inhibitors for Drug-Resistant HIV Infection and HIV-Associated CNS Complications.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00466.
    >> Share

  391. PEREZ-CANTERO A, Lopez-Fernandez L, Guarro J, Capilla J, et al
    New insights into the Cyp51 contribution to azole resistance in Aspergillus section Nigri.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00543.
    >> Share

  392. LARKIN EL, Long L, Isham N, Borroto-Esoda K, et al
    A Novel 1,3-Beta-d-Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  393. KO KKK, Chio MTW, Goh SS, Tan AL, et al
    First Case of Ceftriaxone-Resistant Multidrug-Resistant Neisseria gonorrhoeae in Singapore.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  394. FLAMM RK, Rhomberg PR, Lindley JM, Sweeney K, et al
    Evaluation of the Bactericidal Activity of Fosfomycin in Combination with Selected Antimicrobial Comparison Agents Tested against Gram-Negative Bacterial Strains by Using Time-Kill Curves.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  395. ROSENBLATT J, Vargas-Cruz N, Reitzel RA, Raad II, et al
    Assessment of the Potential for Inducing Resistance in Multidrug-Resistant Organisms from Exposure to Minocycline, Rifampin, and Chlorhexidine Used To Treat Intravascular Devices.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  396. LI J, Hao H, Dai M, Zhang H, et al
    Resistance and Virulence Mechanisms of Escherichia coli Selected by Enrofloxacin in Chicken.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  397. DEMUYSER L, Van Dyck K, Timmermans B, Van Dijck P, et al
    Inhibition of Vesicular Transport Influences Fungal Susceptibility to Fluconazole.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

    April 2019
  398. ERSOY SC, Abdelhady W, Li L, Chambers HF, et al
    Bicarbonate Resensitization of Methicillin-Resistant Staphylococcus aureus to beta-Lactam Antibiotics.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00496.
    >> Share

  399. GHODOUSI A, Tagliani E, Karunaratne E, Niemann S, et al
    Isoniazid resistance in Mycobacterium tuberculosis is a heterogeneous phenotype comprised of overlapping MIC distributions with different underlying resistance mechanisms.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00092.
    >> Share

  400. KIM D, Lee H, Yoon EJ, Hong JS, et al
    Clinical prognoses of patients with a bloodstream infection caused by ampicillin-susceptible but penicillin-resistant Enterococcus faecalis: prospective observational study.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00291.
    >> Share

  401. ADDETIA A, Greninger AL, Adler A, Yuan S, et al
    A novel, widespread qacA allele results in reduced chlorhexidine susceptibility in Staphylococcus epidermidis.
    Antimicrob Agents Chemother. 2019 Apr 15. pii: AAC.02607.
    >> Share

  402. WANG YC, Tang HL, Liao YC, Chiou CS, et al
    Co-carriage of distinct bla KPC-2 and bla OXA-48 plasmids in a single ST11 carbapenem-resistant Klebsiella pneumoniae isolate.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.02282.
    >> Share

  403. SUZUKI Y, Endo S, Nakano R, Nakano A, et al
    Emergence of IMP-34 and OXA-58-producing carbapenem-resistant Acinetobacter colistiniresistens.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.02633.
    >> Share

  404. KEBRIAEI R, Rice SA, Stamper KC, Seepersaud R, et al
    Daptomycin Dose-Ranging Evaluation with Single vs. Multi-Dose Ceftriaxone Combinations against Streptococcus mitis-oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00386.
    >> Share

  405. SIOPI M, Mouton J, Pournaras S, Meletiadis J, et al
    In vitro and in vivo exposure-effect relationship of liposomal amphotericin B against Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.02673.
    >> Share

  406. LOISEAU C, Brites D, Moser I, Coll F, et al
    Revised interpretation of the Hain Lifescience GenoType MTBC to differentiate Mycobacterium canettii and members of the M. tuberculosis complex.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00159.
    >> Share

  407. RANJAN R, Srivastava A, Bharti R, Roy T, et al
    Preclinical development of inhalable D-cycloserine and ethionamide to overcome pharmacokinetic interaction and enhance efficacy against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00099.
    >> Share

  408. LI Y, Liu G, Zhai Z, Liu L, et al
    Erratum for Li et al., "Antibacterial Properties of Magnesium In Vitro and in an In Vivo Model of Implant-Associated Methicillin-Resistant Staphylococcus aureus Infection".
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  409. BI D, Xie R, Zheng J, Yang H, et al
    Large-Scale Identification of AbaR-Type Genomic Islands in Acinetobacter baumannii Reveals Diverse Insertion Sites and Clonal Lineage-Specific Antimicrobial Resistance Gene Profiles.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  410. WALKER GT, Quan J, Higgins SG, Toraskar N, et al
    Predicting Antibiotic Resistance in Gram-Negative Bacilli from Resistance Genes.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  411. DOMALAON R, De Silva PM, Kumar A, Zhanel GG, et al
    The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  412. PUZNIAK L, DePestel DD, Srinivasan A, Ye G, et al
    A Combination Antibiogram Evaluation for Pseudomonas aeruginosa in Respiratory and Blood Sources from Intensive Care Unit (ICU) and Non-ICU Settings in U.S. Hospitals.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  413. DESHPANDE LM, Hubler C, Davis AP, Castanheira M, et al
    Updated Prevalence of mcr-Like Genes among Escherichia coli and Klebsiella pneumoniae in the SENTRY Program and Characterization of mcr-1.11 Variant.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  414. FUCHS F, Hamprecht A
    Results from a Prospective In Vitro Study on the Mecillinam (Amdinocillin) Susceptibility of Enterobacterales.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  415. HUANG Y, Alumasa JN, Callaghan LT, Baugh RS, et al
    A Small-Molecule Inhibitor of trans-Translation Synergistically Interacts with Cathelicidin Antimicrobial Peptides To Impair Survival of Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  416. PHAM CD, Sharpe S, Schlanger K, St Cyr S, et al
    Emergence of Neisseria gonorrhoeae Strains Harboring a Novel Combination of Azithromycin-Attenuating Mutations.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  417. ZHU W, Lawsin A, Lindsey RL, Batra D, et al
    Conjugal Transfer, Whole-Genome Sequencing, and Plasmid Analysis of Four mcr-1-Bearing Isolates from U.S. Patients.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  418. ELNEKAVE E, Hong SL, Lim S, Hayer SS, et al
    Circulation of Plasmids Harboring Resistance Genes to Quinolones and/or Extended-Spectrum Cephalosporins in Multiple Salmonella enterica Serotypes from Swine in the United States.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  419. HTOO HH, Brumage L, Chaikeeratisak V, Tsunemoto H, et al
    Bacterial Cytological Profiling as a Tool To Study Mechanisms of Action of Antibiotics That Are Active against Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  420. REES VE, Deveson Lucas DS, Lopez-Causape C, Huang Y, et al
    Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  421. HUANG YW, Huang HH, Huang KH, Chen WC, et al
    AmpI Functions as an Iron Exporter To Alleviate beta-Lactam-Mediated Reactive Oxygen Species Stress in Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  422. MCPHEE F, Ueland J, Vellucci V, Bowden S, et al
    Impact of Preexisting Hepatitis C Virus Genotype 6 NS3, NS5A, and NS5B Polymorphisms on the In Vitro Potency of Direct-Acting Antiviral Agents.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  423. ZEISER ET, Becka SA, Barnes MD, Taracila MA, et al
    Resurrecting Old beta-Lactams: Potent Inhibitory Activity of Temocillin against Multidrug-Resistant Burkholderia Species Isolates from the United States.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  424. CHENG A, Tsai YT, Chang SY, Sun HY, et al
    In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  425. ASEMPA TE, Motos A, Abdelraouf K, Bissantz C, et al
    Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine beta-Lactamase-Producing Enterobacteriaceae in the Neutropenic Murine Lung Infection Model.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  426. YIN D, Wu S, Yang Y, Shi Q, et al
    Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the In Vitro Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  427. TETZ G, Collins M, Vikina D, Tetz V, et al
    In Vitro Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of Candida glabrata, Candida auris, Cryptococcus neoformans, and Pneumocystis spp.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  428. KUMAR M, Rao M, Purnapatre KP, Barman TK, et al
    DS86760016, a Leucyl-tRNA Synthetase Inhibitor with Activity against Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  429. SASS A, Slachmuylders L, Van Acker H, Vandenbussche I, et al
    Various Evolutionary Trajectories Lead to Loss of the Tobramycin-Potentiating Activity of the Quorum-Sensing Inhibitor Baicalin Hydrate in Burkholderia cenocepacia Biofilms.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  430. KARLOWSKY JA, Kazmierczak KM, Bouchillon SK, de Jonge BLM, et al
    In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  431. CAO H, Xia T, Li Y, Xu Z, et al
    Uncoupled Quorum Sensing Modulates the Interplay of Virulence and Resistance in a Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolate Belonging to the MLST550 Clonal Complex.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  432. BHAGWAT SS, Periasamy H, Takalkar SS, Palwe SR, et al
    The Novel beta-Lactam Enhancer Zidebactam Augments the In Vivo Pharmacodynamic Activity of Cefepime in a Neutropenic Mouse Lung Acinetobacter baumannii Infection Model.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  433. ARASTEHFAR A, Daneshnia F, Zomorodian K, Najafzadeh MJ, et al
    Low level of antifungal resistance in Iranian isolates of Candida glabrata recovered from blood samples from multicenter (2015-2018): Potential prognostic values of genotyping and sequencing of PDR1.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.02503.
    >> Share

    March 2019
  434. MALEK A, McGlynn K, Taffner S, Fine L, et al
    Next-generation sequencing based hospital outbreak investigation yields insight into Klebsiella aerogenes population structure and determinants of carbapenem resistance and pathogenicity.
    Antimicrob Agents Chemother. 2019 Mar 25. pii: AAC.02577.
    >> Share

  435. MENDES RE, Castanheira M, Woosley LN, Stone GG, et al
    Characterization of beta-lactamase content of ceftazidime-resistant pathogens recovered during the pathogen-directed Phase 3 trial (REPRISE) for ceftazidime-avibactam: Correlation of efficacy against beta-lactamase producers.
    Antimicrob Agents Chemother. 2019 Mar 25. pii: AAC.02655.
    >> Share

  436. NISHIMOTO AT, Wiederhold NP, Flowers SA, Zhang Q, et al
    In vitro activities of the novel investigational tetrazoles VT-1161 and VT-1598 compared to the triazole antifungals against azole-resistant strains and clinical isolates of Candida albicans.
    Antimicrob Agents Chemother. 2019 Mar 25. pii: AAC.00341.
    >> Share

  437. BECCARI MV, Mogle BT, Sidman EF, Mastro KA, et al
    Ibalizumab: A novel monoclonal antibody for the management of multidrug resistant HIV-1 infection.
    Antimicrob Agents Chemother. 2019 Mar 18. pii: AAC.00110.
    >> Share

  438. GERIAK M, Haddad F, Rizvi K, Rose W, et al
    Clinical Data on Daptomycin Plus Ceftaroline Versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.02483.
    >> Share

  439. JANARDHANAN J, Bouley R, Martinez-Caballero S, Peng Z, et al
    The quinazolinone allosteric inhibitor of PBP2a synergizes with piperacillin and tazobactam against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.02637.
    >> Share

  440. FUJII H, Harada S, Yoshikawa T, Yamada S, et al
    Differences in the likelihood of acyclovir resistance-associated mutations in the thymidine kinase genes of herpes simplex virus 1 and varicella-zoster virus.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00017.
    >> Share

  441. DUMKE R, Ziegler T
    Long-term low rate of macrolide resistant Mycoplasma pneumoniae strains in Germany.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00455.
    >> Share

  442. SANZ-GARCIA F, Alvarez-Ortega C, Olivares-Pacheco J, Blanco P, et al
    Analysis of the Pseudomonas aeruginosa aminoglycosides differential resistome allows defining genes simultaneously involved in intrinsic antibiotic resistance and virulence.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00185.
    >> Share

  443. BUTTS A, Reitler P, Nishimoto AT, DeJarnette C, et al
    A systematic screen reveals a diverse collection of medications induce antifungal resistance in Candida species.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00054.
    >> Share

  444. NISHIMOTO AT, Zhang Q, Hazlett B, Morschhauser J, et al
    The contribution of clinically-derived mutations in the gene encoding the zinc cluster transcription factor Mrr2 to fluconazole antifungal resistance and CDR1 expression in Candida albicans.
    Antimicrob Agents Chemother. 2019 Mar 4. pii: AAC.00078.
    >> Share

  445. TOMICH AD, Klontz EH, Deredge D, Barnard JP, et al
    Small-Molecule Inhibitor of FosA Expands Fosfomycin Activity to Multidrug-Resistant Gram-Negative Pathogens.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  446. KHANDELWAL NK, Wasi M, Nair R, Gupta M, et al
    Vacuolar Sequestration of Azoles, a Novel Strategy of Azole Antifungal Resistance Conserved across Pathogenic and Nonpathogenic Yeast.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  447. CONNOLLY KL, Eakin AE, Gomez C, Osborn BL, et al
    Pharmacokinetic Data Are Predictive of In Vivo Efficacy for Cefixime and Ceftriaxone against Susceptible and Resistant Neisseria gonorrhoeae Strains in the Gonorrhea Mouse Model.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  448. HENLY EL, Dowling JAR, Maingay JB, Lacey MM, et al
    Biocide Exposure Induces Changes in Susceptibility, Pathogenicity, and Biofilm Formation in Uropathogenic Escherichia coli.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  449. GERSON S, Betts JW, Lucassen K, Nodari CS, et al
    Investigation of Novel pmrB and eptA Mutations in Isogenic Acinetobacter baumannii Isolates Associated with Colistin Resistance and Increased Virulence In Vivo.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  450. SUGAWARA Y, Akeda Y, Hagiya H, Sakamoto N, et al
    Spreading Patterns of NDM-Producing Enterobacteriaceae in Clinical and Environmental Settings in Yangon, Myanmar.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  451. KAUSHIK A, Ammerman NC, Lee J, Martins O, et al
    In Vitro Activity of the New beta-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with beta-Lactams against Mycobacterium abscessus Complex Clinical Isolates.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  452. PEREZ-VARELA M, Corral J, Aranda J, Barbe J, et al
    Roles of Efflux Pumps from Different Superfamilies in the Surface-Associated Motility and Virulence of Acinetobacter baumannii ATCC 17978.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  453. ISMAIL N, Peters RPH, Ismail NA, Omar SV, et al
    Clofazimine Exposure In Vitro Selects Efflux Pump Mutants and Bedaquiline Resistance.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  454. STROM HALLENBERG G, Borjesson S, Sokerya S, Sothyra T, et al
    Detection of mcr-Mediated Colistin Resistance in Escherichia coli Isolates from Pigs in Small-Scale Farms in Cambodia.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  455. SHEN D, Ma G, Li C, Jia X, et al
    Emergence of a Multidrug-Resistant Hypervirulent Klebsiella pneumoniae Sequence Type 23 Strain with a Rare bla CTX-M-24-Harboring Virulence Plasmid.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  456. SHU L, Dong N, Lu J, Zheng Z, et al
    Emergence of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae That Carries a pLVPK-Like Virulence Plasmid among Elderly Patients in China.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

    February 2019
  457. WOZNIAK JE, Band VI, Conley A, Rishishwar L, et al
    A Nationwide Screen of carbapenem-resistant Klebsiella pneumoniae reveals an isolate with enhanced virulence and clinically undetected colistin-heteroresistance.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.00107.
    >> Share

  458. NAKANO S, Fujisawa T, Ito Y, Chang B, et al
    Whole-genome sequencing analysis of multidrug-resistant serotype 15A Streptococcus pneumoniae in Japan and the emergence of a highly resistant serotype 15A-ST9084 clone.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.02579.
    >> Share

  459. SMITH RA, Raugi DN, Wu VH, Zavala CG, et al
    Comparison of the Antiviral Activity of Bictegravir Against HIV-1 and HIV-2 Isolates and Integrase Inhibitor-Resistant HIV-2 Mutants.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.00014.
    >> Share

  460. ACOSTA RK, Willkom M, Martin R, Chang S, et al
    Resistance Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment-Naive Patients Through 48 Weeks.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.02533.
    >> Share

  461. BAINES SL, Jensen SO, Firth N, Goncalves da Silva A, et al
    Remodelling of pSK1 Family Plasmids and Enhanced Chlorhexidine Tolerance in a Dominant Hospital Lineage of Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02356.
    >> Share

  462. LIESE J, Schule L, Oberhettinger P, Tschorner L, et al
    Expansion of Vancomycin-resistant Enterococcus faecium in an academic tertiary hospital in Southwest Germany: a large-scale whole genome-based outbreak investigation.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.01978.
    >> Share

  463. GINGRAS H, Patron K, Bhattacharya A, Leprohon P, et al
    Gain and loss of function screens coupled to next generation sequencing for antibiotic mode of action and resistance studies in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02381.
    >> Share

  464. BIAN X, Liu X, Chen Y, Chen D, et al
    Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Chinese Hospital-acquired Pneumonia Patients Using In Vitro PK/PD Model.
    Antimicrob Agents Chemother. 2019 Feb 11. pii: AAC.01989.
    >> Share

  465. HONG SI, Lee YM, Park KH, Ryu BH, et al
    Clinical and Molecular Characteristics of qacA/B-Positive Methicillin-resistant Staphylococcus aureus Causing Bloodstream Infections.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02157.
    >> Share

  466. KINNEAR CL, Patel TS, Young CL, Marshall V, et al
    Impact of an antimicrobial stewardship intervention on within and between patient daptomycin resistance evolution in vancomycin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.01800.
    >> Share

  467. GYGLI SM, Keller PM, Ballif M, Blochliger N, et al
    Whole genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02175.
    >> Share

  468. RYBAK JM, Doorley LA, Nishimoto AT, Barker KS, et al
    Abrogation of triazole resistance upon deletion of CDR1 in a clinical isolate of Candida auris.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.00057.
    >> Share

  469. KOVACS R, Holzknecht J, Hargitai Z, Papp C, et al
    In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  470. YE M, Xu L, Zou Y, Li B, et al
    Molecular Analysis of Linezolid-Resistant Clinical Isolates of Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  471. STAINTON SM, Monogue ML, Tsuji M, Yamano Y, et al
    Efficacy of Humanized Cefiderocol Exposures over 72 Hours against a Diverse Group of Gram-Negative Isolates in the Neutropenic Murine Thigh Infection Model.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  472. WALSH SI, Peters DS, Smith PA, Craney A, et al
    Inhibition of Protein Secretion in Escherichia coli and Sub-MIC Effects of Arylomycin Antibiotics.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  473. STEWART NK, Smith CA, Antunes NT, Toth M, et al
    Role of the Hydrophobic Bridge in the Carbapenemase Activity of Class D beta-Lactamases.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  474. FERNANDEZ-CRUZ A, Alba N, Semiglia-Chong MA, Padilla B, et al
    A Case-Control Study of Real-Life Experience with Ceftolozane-Tazobactam in Patients with Hematologic Malignancy and Pseudomonas aeruginosa Infection.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  475. TRAN TT, Mishra NN, Seepersaud R, Diaz L, et al
    Mutations in cdsA and pgsA Correlate with Daptomycin Resistance in Streptococcus mitis and S. oralis.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  476. GUIRAL E, Goncalves Quiles M, Munoz L, Moreno-Morales J, et al
    Emergence of Resistance to Quinolones and beta-Lactam Antibiotics in Enteroaggregative and Enterotoxigenic Escherichia coli Causing Traveler's Diarrhea.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

    January 2019
  477. CHEN FJ, Huang WC, Liao YC, Wang HY, et al
    Molecular Epidemiology of Emerging Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter pittii in Taiwan, 2010-2014.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02007.
    >> Share

  478. LIN YW, Abdul Rahim N, Zhao J, Han ML, et al
    Novel Polymyxin Combination with Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-producing MDR Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02176.
    >> Share

  479. INDIANI C, Sauve K, Raz A, Abdelhady W, et al
    The Anti-Staphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood to Potentiate MRSA Bacteriolysis.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02291.
    >> Share

  480. KEBRIAEI R, Rice SA, Stamper KC, Rybak MJ, et al
    Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a PK/PD Model.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01743.
    >> Share

  481. O'DONNELL MR, Larsen MH, Brown TS, Jain P, et al
    Early detection of emergent extensively drug resistant tuberculosis (XDR-TB) by flow cytometry-based phenotyping and whole genome sequencing.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01834.
    >> Share

  482. HIGASHI-KUWATA N, Hayashi S, Das D, Kohgo S, et al
    CMCdG, a novel nucleoside analog, exerts potent activity against wild-type and entecavir-resistant HBV with favorable safety feature.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02143.
    >> Share

  483. RUIZ P, Causse M, Vaquero M, Casal M, et al
    In vitro activity of Tedizolid against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01939.
    >> Share

  484. GELADARI A, Simitsopoulou M, Antachopoulos C, Roilides E, et al
    Dose-dependent Synergistic Interactions of Colistin with Rifampicin, Meropenem and Tigecycline against Carbapenem-resistant Klebsiella pneumoniae Biofilms.
    Antimicrob Agents Chemother. 2019 Jan 14. pii: AAC.02357.
    >> Share

  485. VALENTINE-KING MA, Cisneros K, James MO, Huigens RW 3rd, et al
    Turning the Tide against Antibiotic Resistance by Evaluating Novel, Halogenated Phenazine, Quinoline, and NH125 Compounds against Ureaplasma spp. Clinical Isolates and Mycoplasma Type Strains.
    Antimicrob Agents Chemother. 2019 Jan 14. pii: AAC.02265.
    >> Share

  486. TURNER N, Strand A, Grewal DS, Cox G, et al
    Use of Letermovir as Salvage Therapy for Drug-resistant CMV Retinitis: A Case Series.
    Antimicrob Agents Chemother. 2019 Jan 14. pii: AAC.02337.
    >> Share

  487. MARSHALL AC, Kidd SE, Lamont-Friedrich SJ, Arentz G, et al
    Aspergillus fumigatus thioredoxin reductase: structure, mechanism, and inhibition.
    Antimicrob Agents Chemother. 2019 Jan 14. pii: AAC.02281.
    >> Share

  488. DILWORTH TJ, Casapao AM, Ibrahim OM, Jacobs DM, et al
    Adjuvant beta-lactam therapy combined with vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Does beta-lactam class matter?
    Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.02211.
    >> Share

  489. WILSON WR, Kline EG, Jones CE, Morder KT, et al
    Effects of KPC variant and porin genotype on the in vitro activity of meropenem-vaborbactam against carbapenem-resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.02048.
    >> Share

  490. JIANG JH, Dexter C, Cameron DR, Monk IR, et al
    Evolution of daptomycin resistance in coagulase negative staphylococci involves mutations of the essential two component regulator WalKR.
    Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.01926.
    >> Share

  491. KHALIL ZG, Hill TA, De Leon Rodriguez LM, Lohman RJ, et al
    Structure-activity relationships of wollamide cyclic hexapeptides with activity against drug-resistant and intracellular Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.01773.
    >> Share

  492. GHAJAVAND H, Kargarpour Kamakoli M, Khanipour S, Pourazar Dizaji S, et al
    High Prevalence of Bedaquiline Resistance in Treatment-naive Tuberculosis Patients and Verapamil Effectiveness.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.02530.
    >> Share

  493. YOSHINAGA T, Miki S, Kawauchi-Miki S, Seki T, et al
    Barrier to resistance of dolutegravir in two-drug combinations.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.02104.
    >> Share

  494. ATHANS V, Neuner EA, Hassouna H, Richter SS, et al
    Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-Resistant Klebsiella pneumoniae Bacteremia and Abscess in a Liver Transplant Recipient.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  495. YANG Y, Xu Q, Li T, Fu Y, et al
    OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  496. SABET M, Tarazi Z, Griffith DC
    Activity of Meropenem-Vaborbactam against Pseudomonas aeruginosa and Acinetobacter baumannii in a Neutropenic Mouse Thigh Infection Model.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  497. BUSS JA, Baidin V, Welsh MA, Flores-Kim J, et al
    Pathway-Directed Screen for Inhibitors of the Bacterial Cell Elongation Machinery.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  498. GIRLICH D, Naas T, Dortet L
    Comparison of the Superpolymyxin and ChromID Colistin R Screening Media for the Detection of Colistin-Resistant Enterobacteriaceae from Spiked Rectal Swabs.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  499. MONK BC, Keniya MV, Sabherwal M, Wilson RK, et al
    Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  500. KARLOWSKY JA, Adam HJ, Baxter MR, Denisuik AJ, et al
    In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  501. KOTSAKIS SD, Flach CF, Razavi M, Larsson DGJ, et al
    Characterization of the First OXA-10 Natural Variant with Increased Carbapenemase Activity.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  502. HUBER L, Giguere S, Slovis NM, Carter CN, et al
    Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  503. JOHNSON TJ, Elnekave E, Miller EA, Munoz-Aguayo J, et al
    Phylogenomic Analysis of Extraintestinal Pathogenic Escherichia coli Sequence Type 1193, an Emerging Multidrug-Resistant Clonal Group.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  504. PALACIOS AR, Mojica MF, Giannini E, Taracila MA, et al
    The Reaction Mechanism of Metallo-beta-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  505. SOLIMAN AM, Shimamoto T, Nariya H, Shimamoto T, et al
    Emergence of Salmonella Genomic Island 1 Variant SGI1-W in a Clinical Isolate of Providencia stuartii from Egypt.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  506. POIREL L, Ortiz De La Rosa JM, Kieffer N, Dubois V, et al
    Acquisition of Extended-Spectrum beta-Lactamase GES-6 Leading to Resistance to Ceftolozane-Tazobactam Combination in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  507. WEINSTEIN ZB, Zaman MH
    Evolution of Rifampin Resistance in Escherichia coli and Mycobacterium smegmatis Due to Substandard Drugs.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  508. ZHANEL G, Critchley I, Lin LY, Alvandi N, et al
    Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  509. FIESTER SE, Arivett BA, Beckett AC, Wagner BR, et al
    Miltefosine Reduces the Cytolytic Activity and Virulence of Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

  510. RICHARD M, Gutierrez AV, Viljoen A, Rodriguez-Rincon D, et al
    Mutations in the MAB_2299c TetR Regulator Confer Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2018;63.
    >> Share

    December 2018
  511. BORDALLO-CARDONA MA, Sanchez-Carrillo C, Bouza E, Munoz P, et al
    Detection of echinocandin-resistant Candida glabrata in blood cultures spiked with different percentages of FKS2 mutants.
    Antimicrob Agents Chemother. 2018 Dec 17. pii: AAC.02004.
    >> Share

  512. PECORA N, Zhao X, Nudel K, Hoffmann M, et al
    Diverse vectors and mechanisms spread NDM beta-lactamases among carbapenem resistant Enterobacteriaceae in the Greater Boston area.
    Antimicrob Agents Chemother. 2018 Dec 10. pii: AAC.02040.
    >> Share

  513. DONG N, Liu L, Zhang R, Chen K, et al
    An IncR Plasmid harbored by a hypervirulent, carbapenem resistant Klebsiella pneumoniae strain possesses five tandem repeats of the bla KPC-2::NTEKPC-Id fragment.
    Antimicrob Agents Chemother. 2018 Dec 10. pii: AAC.01775.
    >> Share

  514. MATSUO M, Hiramatsu M, Singh M, Sasaki T, et al
    Genetic and transcriptomic analyses of ciprofloxacin-tolerant Staphylococcus aureus isolated by the Replica Plating Tolerance Isolation System (REPTIS).
    Antimicrob Agents Chemother. 2018 Dec 3. pii: AAC.02019.
    >> Share

  515. MELETIADIS J, Turlej-Rogacka A, Lerner A, Adler A, et al
    Erratum for Meletiadis et al., "Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

    November 2018
  516. MATSUO M, Yamamoto N, Hishinuma T, Hiramatsu K, et al
    Identification of a novel gene associated with high-level beta-lactam resistance in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3 and methicillin-resistant S. aureus strain N315.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.00712.
    >> Share

  517. SCHIAFFINO F, Colston JM, Paredes Olortegui M, Francois R, et al
    Antibiotic Resistance of Campylobacter spp. in a Pediatric Cohort Study.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01911.
    >> Share

  518. CHOJNACKI M, Philbrick A, Wucher B, Reed JN, et al
    Development of a broad-spectrum antimicrobial combination for the treatment of Staphylococcus aureus and Pseudomonas aeruginosa corneal infections.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01929.
    >> Share

  519. ZHENG H, Liu D, Lu J, Song Y, et al
    Genetic correlation of antibiotic susceptibility and resistance genotyping for Mycobacterium abscessus group.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01523.
    >> Share

  520. MACDONALD D, Thomson DD, Johns A, Contreras Valenzuela A, et al
    Inducible cell fusion permits use of competitive fitness profiling in the human pathogenic fungus Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01615.
    >> Share

  521. BARROS EM, Martin MJ, Selleck EM, Lebreton F, et al
    Daptomycin resistance and tolerance due to loss-of-function in Staphylococcus aureus dsp1 and asp23.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01542.
    >> Share

  522. GOODLET KJ, Benhalima FZ, Nailor MD
    A systematic review of single-dose aminoglycoside therapy for urinary tract infection: Is it time to resurrect an old strategy?
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.02165.
    >> Share

  523. DE MIRANDA SILVA C, Hajihosseini A, Myrick J, Nole J, et al
    Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log-phase, Acid-phase and Non-Replicating-Persister (NRP)-phase in an in vitro Assay.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01695.
    >> Share

  524. HOU X, Lee A, Jimenez-Ortigosa C, Kordalewska M, et al
    Rapid Detection of ERG11-Associated Azole Resistance and FKS-Associated Echinocandin Resistance in Candida auris.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01811.
    >> Share

  525. CHOI MJ, Won EJ, Joo MY, Park YJ, et al
    Emergence of Voriconazole-resistant Aspergillus flavus Isolates in Korean Hospitals: Microsatellite Typing and Resistance Mechanism Analysis.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01610.
    >> Share

  526. PICCINELLI G, Fernandes P, Bonfanti C, Caccuri F, et al
    Erratum for Piccinelli et al., "In Vitro Activity of Solithromycin against Erythromycin-Resistant Streptococcus agalactiae".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

    October 2018
  527. TAMMA PD, Fan Y, Bergman Y, Pertea G, et al
    Applying Rapid Whole Genome Sequencing to Predict Phenotypic Antimicrobial Susceptibility Testing Results Among Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01923.
    >> Share

  528. HU Y, Liu Y, Coates A
    Azidothymidine produces synergistic activity in combination with colistin against antibiotic-resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01630.
    >> Share

  529. ALMARZOKY ABUHUSSAIN SS, Avery LM, Abdelraouf K, Nicolau DP, et al
    In Vivo Efficacy of Humanized WCK 5222 (Cefepime-Zidebactam) Exposures Against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Thigh Model.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01931.
    >> Share

  530. SHIELDS RK, Kline EG, Healey KR, Kordalewska M, et al
    Spontaneous mutational frequency and FKS mutation rates vary by echinocandin agent against Candida glabrata.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01692.
    >> Share

  531. WANG Y, Mukhopadhyay R, Roy S, Kapoor A, et al
    Inhibition of Cytomegalovirus Replication with Extended Half-Life Synthetic Ozonides.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01735.
    >> Share

  532. WANG X, Wang Q, Cao B, Sun S, et al
    Impact of Combination Therapy vs Monotherapy on Mortality from Carbapenem-Resistant Enterobacteriaceae Bacteremia: A Retrospective Observational Study from a Chinese Network.
    Antimicrob Agents Chemother. 2018 Oct 22. pii: AAC.01511.
    >> Share

  533. CAVALHEIRO M, Costa C, Silva-Dias A, Miranda IM, et al
    Unveiling the mechanisms of in vitro evolution towards fluconazole resistance of a Candida glabrata clinical isolate: a transcriptomics approach.
    Antimicrob Agents Chemother. 2018 Oct 22. pii: AAC.00995.
    >> Share

  534. TANABE K, Bonus M, Tomiyama S, Miyoshi K, et al
    FK506 resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 involves mutations in the transmembrane domains and extracellular loops.
    Antimicrob Agents Chemother. 2018 Oct 22. pii: AAC.01146.
    >> Share

  535. JACOBS MR, Abdelhamed AM, Good CE, Rhoads DD, et al
    ARGONAUT-I: Activity of cefiderocol (S-649266), a siderophore cephalosporin, against Gram-negative bacteria including carbapenem resistant nonfermenters and Enterobacteriaceae with defined extended-spectrum beta-lactamases and carbapenemases.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01801.
    >> Share

  536. ISLER B, Doi Y, Bonomo RA, Paterson DL, et al
    New Treatment Options Against Carbapenem-Resistant Acinetobacter baumannii Infections.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01110.
    >> Share

  537. ESPINEL-INGROFF A, Turnidge J, Alastruey-Izquierdo A, Botterel F, et al
    Method-dependent epidemiological cutoff values (ECVs) for detection of triazole resistance in Candida and Aspergillus species for the SYO colorimetric broth and Etest agar diffusion methods.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01651.
    >> Share

  538. LUNA-TAPIA A, Butts A, Palmer GE
    Loss of C-5 sterol desaturase activity in Candida albicans - azole resistance or merely trailing growth?
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01337.
    >> Share

  539. ROUARD C, Garnier F, Leraut J, Lepainteur M, et al
    Emergence and within-host genetic evolution of methicillin-resistant Staphylococcus aureus resistant to linezolid in a cystic fibrosis patient.
    Antimicrob Agents Chemother. 2018 Oct 1. pii: AAC.00720.
    >> Share

    September 2018
  540. PADILLA E, Oms L, Espejo E, Gomez L, et al
    Rifampin resistance in staphylococci after rifaximin intake for surgical prophylaxis in elective colorectal surgery.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01353.
    >> Share

  541. RAMIREZ-ZAVALA B, Manz H, Englert F, Rogers PD, et al
    A hyperactive form of the zinc cluster transcription factor Stb5 causes YOR1 overexpression and beauvericin resistance in Candida albicans.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01655.
    >> Share

  542. DOAN TN, Cao P, Emeto TI, McCaw JM, et al
    Predicting the Outcomes of New Short-Course Regimens for Multi-Drug Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modelling.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01487.
    >> Share

  543. LOUIE A, Duncanson B, Myrick J, Maynard M, et al
    The Activity of Moxifloxacin against Acid-Phase and Non-Replicative Persister Phenotype Phase Mycobacterium tuberculosis in a Hollow Fiber Infection Model.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01470.
    >> Share

  544. TAN D, Htun HL, Koh J, Kanagasabai K, et al
    Comparative epidemiology of vancomycin-resistant enterococci colonization in an acute care hospital and its affiliated intermediate- and long-term care facilities in Singapore.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01507.
    >> Share

  545. MARTIN LW, Robson CL, Watts AM, Gray AR, et al
    Expression of Pseudomonas aeruginosa antibiotic resistance genes varies greatly during infections in cystic fibrosis patients.
    Antimicrob Agents Chemother. 2018 Sep 10. pii: AAC.01789.
    >> Share

  546. FARRUKEE R, Zarebski AE, McCaw JM, Bloom JD, et al
    CHARACTERIZATION OF INFLUENZA B VIRUS VARIANTS WITH REDUCED NEURAMINIDASE INHIBITOR SUSCEPTIBILITY.
    Antimicrob Agents Chemother. 2018 Sep 10. pii: AAC.01081.
    >> Share

  547. DOMON H, Maekawa T, Yonezawa D, Nagai K, et al
    Mechanism of macrolide-induced inhibition of pneumolysin release involves impairment of autolysin release in macrolide-resistant Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2018 Sep 4. pii: AAC.00161.
    >> Share

  548. AVERY LM, Abdelraouf K, Nicolau DP
    Assessment of the In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) Against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Murine Lung Infection Model.
    Antimicrob Agents Chemother. 2018 Sep 4. pii: AAC.00948.
    >> Share

    August 2018
  549. BALLABEN AS, Andrade LN, Galetti R, Ferreira JC, et al
    Diversity of high-level aminoglycoside resistance mechanisms among Gram-negative nosocomial pathogens in Brazil.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.01550.
    >> Share

  550. CARTER GP, Ussher JE, Goncalves Da Silva A, Baines SL, et al
    Genomic analysis of multi-resistant Staphylococcus capitis associated with neonatal sepsis.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.00898.
    >> Share

  551. MA P, Laibinis HH, Ernst CM, Hung DT, et al
    Carbapenem resistance caused by high-level expression of OXA-663 beta-lactamase in an OmpK36-deficient Klebsiella pneumoniae clinical isolate.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01281.
    >> Share

  552. ROUARD C, Doucet-Populaire F, Guillet-Caruba C, Villet M, et al
    Deletion of one 23S rDNA (rrl) copy contributes to the development of resistance to linezolid in Staphylococcus warneri.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01139.
    >> Share

  553. UKAI Y, Kuroiwa M, Kurihara N, Naruse H, et al
    Contributions of yap1 mutation and subsequent atrF upregulation to voriconazole resistance in Aspergillus flavus.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01216.
    >> Share

  554. KENIYA MV, Ruma YN, Tyndall JDA, Monk BC, et al
    Heterologous expression of full-length lanosterol 14alpha-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provides tools for antifungal discovery.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01131.
    >> Share

  555. PAUL RA, Rudramurthy SM, Dhaliwal M, Singh P, et al
    Voriconazole resistance in clinical and environmental isolates of Aspergillus flavus - frequency and investigation into the role of multidrug efflux pumps.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01022.
    >> Share

  556. LUPIEN A, Vocat A, Foo CS, Blattes E, et al
    An optimized background regimen for treatment of active tuberculosis with the next-generation benzothiazinone Macozinone (PBTZ169).
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.00840.
    >> Share

  557. WALL G, Chaturvedi AK, Wormley FL Jr, Wiederhold NP, et al
    Screening a Repurposing Library for Inhibitors of Multi-Drug Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.01084.
    >> Share

  558. BANERJEE SK, Farber JM
    Trend and pattern of antimicrobial resistance in molluscan Vibrio species sourced to Canadian estuaries.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00799.
    >> Share

  559. KANDLER JL, Mercante AD, Dalton TL, Ezewudo MN, et al
    Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00974.
    >> Share

  560. ISLA G, Leonardelli F, Tiraboschi IN, Refojo N, et al
    First clinical isolation of an azole-resistant Aspergillus fumigatus harboring a TR46/Y121F/T289A mutation in South America.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00872.
    >> Share

  561. HEALEY KR, Kordalewska M, Jimenez Ortigosa C, Singh A, et al
    Limited ERG11 mutations identified in isolates of Candida auris directly contribute to reduced azole susceptibility.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.01427.
    >> Share

    July 2018
  562. WEIKUM J, Ritzmann N, Jelden N, Klockner A, et al
    Sulfide protects Staphylococcus aureus from aminoglycoside antibiotics but cannot be regarded as a general defense mechanism against antibiotics.
    Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.00602.
    >> Share

  563. RAZ A, Serrano A, Thaker M, Alston T, et al
    Lysostaphin lysibody leads to effective opsonization and killing of methicillin resistant Staphylococcus aureus in a murine model.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.01056.
    >> Share

  564. CATHCART AL, Chan HL, Bhardwaj N, Liu Y, et al
    No Resistance to Tenofovir Alafenamide Detected Through 96 Weeks of Treatment in Patients with Chronic Hepatitis B.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.01064.
    >> Share

  565. WHALEY SG, Zhang Q, Caudle KE, Rogers PD, et al
    Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.01070.
    >> Share

  566. YAN Q, Karau MJ, Raval YS, Patel R, et al
    Evaluation of Oritavancin in Combination with Rifampin, Gentamicin or Linezolid Against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00943.
    >> Share

  567. MONOGUE ML, Giovagnoli S, Bissantz C, Zampaloni C, et al
    In Vivo Efficacy of Meropenem, with a novel non-beta-lactam beta-lactamase Inhibitor, Nacubactam, against Gram-negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.02596.
    >> Share

  568. KIDD JM, Abdelraouf K, Asempa TE, Humphries RM, et al
    Pharmacodynamics of Daptomycin Against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00506.
    >> Share

  569. HONDA H, Sato T, Shinagawa M, Fukushima Y, et al
    Multiclonal expansion and high prevalence of beta-lactamase-negative high-level ampicillin-resistant Haemophilus influenzae in Japan, and susceptibility to quinolones.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.00851.
    >> Share

  570. SMITH SJ, Zhao XZ, Burke TR Jr, Hughes SH, et al
    HIV-1 integrase inhibitors that are broadly effective against drug-resistant mutants.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.01035.
    >> Share

  571. CAI Y, Seah CL, Leck H, Lim TP, et al
    Rapid antibiotic combination testing for carbapenem-resistant Gram negative bacteria within 6h using adenosine triphosphate bioluminescence.
    Antimicrob Agents Chemother. 2018 Jul 2. pii: AAC.00183.
    >> Share

  572. SUN E, Gill EE, Falsafi R, Yeung A, et al
    Broad-spectrum adaptive antibiotic resistance associated with Pseudomonas aeruginosa mucin-dependent surfing motility.
    Antimicrob Agents Chemother. 2018 Jul 2. pii: AAC.00848.
    >> Share

  573. PARDOS DE LA GANDARA M, Borges V, Chung M, Milheirico C, et al
    Correction for Pardos de la Gandara et al., "Genetic Determinants of High-Level Oxacillin Resistance in Methicillin-Resistant Staphylococcus aureus".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

    June 2018
  574. LEE H, Yoon EJ, Kim D, Kim JW, et al
    Ceftaroline resistance by clone-specific polymorphism in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00485.
    >> Share

  575. PEREZ-VARELA M, Corral J, Aranda J, Barbe J, et al
    Functional characterization of AbaQ, a novel efflux pump mediating quinolone resistance in Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00906.
    >> Share

  576. TAJ-ALDEEN SJ, Salah H, Perez WB, Almaslamani M, et al
    Molecular analysis of resistance and detection of non-wild type strains using ECV values of Etest for amphotericin B and echinocandins for bloodstream Candida infections from a tertiary hospital in Qatar.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00214.
    >> Share

  577. RANCOITA PMV, Cugnata F, Gibertoni Cruz AL, Borroni E, et al
    Validating a 14-drug microtitre plate containing bedaquiline and delamanid for large-scale research susceptibility testing of Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00344.
    >> Share

  578. CAMPEAU SA, Schuetz AN, Kohner P, Arias CA, et al
    Variability of daptomycin minimum inhibitory concentrations for Enterococcus faecium when measured by reference broth microdilution and gradient diffusion tests.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00745.
    >> Share

  579. VACCA P, Fazio C, Neri A, Ambrosio L, et al
    Neisseria meningitidis antimicrobial resistance in Italy, 2006-2016.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00207.
    >> Share

  580. ROBIN F, Auzou M, Bonnet R, Lebreuilly R, et al
    In vitro activity of ceftolozane-tazobactam against Enterobacter cloacae complex clinical isolates with different beta-lactam resistance phenotypes.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00675.
    >> Share

  581. XIE Y, Zhu Z, Wang J, Zhang L, et al
    Ten-day quadruple therapy comprising low-dose rabeprazole, bismuth, amoxicillin and tetracycline is an effective and safe first-line treatment for Helicobacter pylori infection in population with high antibiotic resistance: a prospective, multicenter,
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00432.
    >> Share

  582. ALMARZOKY ABUHUSSAIN SS, Kuti JL, Nicolau DP
    Antibacterial Activity of Human Simulated Epithelial Lining Fluid Concentrations of Ceftazidime-Avibactam Alone or in Combination with Amikacin Inhale (BAY41-6551) against Carbapenem Resistant Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00113.
    >> Share

  583. CHOU S, Satterwhite LE, Ercolani RJ
    A New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by in vitro Exposure to Letermovir and Ganciclovir.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00922.
    >> Share

  584. UMEYAMA T, Hayashi Y, Shimosaka H, Inukai T, et al
    Cas9/CRISPR genome editing to demonstrate the contribution of Cyp51A Gly138Ser to azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00894.
    >> Share

  585. YU F, Lv J, Niu S, Du H, et al
    In Vitro activity of ceftazidime-avibactam against carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.01031.
    >> Share

  586. SHIELDS RK, Nguyen MH, Hao B, Kline EG, et al
    Colistin does not potentiate ceftazidime-avibactam killing of carbapenem-resistant Enterobacteriaceae in vitro or suppress emergence of ceftazidime-avibactam resistance.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.01018.
    >> Share

  587. KARALEWITZ AP, Miller SI
    Multiple drug resistant Acinetobacter baumannii chloramphenicol resistance requires an inner membrane permease.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00513.
    >> Share

  588. KIDDEE A, Assawatheptawee K, Na-Udom A, Treebupachatsakul P, et al
    Risk factors for gastrointestinal colonization and acquisition of carbapenem-resistant Gram-negative bacteria among patients in intensive care units in Thailand.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00341.
    >> Share

  589. TRUONG-BOLDUC QC, Wang Y, Hooper DC
    Tet38 Efflux Pump Contributes to Fosfomycin Resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00927.
    >> Share

  590. DABAS Y, Xess I, Bakshi S, Mahapatra M, et al
    "Emergence of azole resistant Aspergillus fumigatus from immunocompromised hosts in India".
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.02264.
    >> Share

  591. CASTANHEIRA M, Davis AP, Mendes RE, Serio AW, et al
    In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from United States Hospitals and Comparative Activity of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Gen
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00313.
    >> Share

  592. DE MIRANDA SILVA C, Hajihosseini A, Myrick J, Nole J, et al
    Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log-Phase, Acid-Phase and Non-Replicating-Persister (NRP)-Phase in an In vitro Assay.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00856.
    >> Share

    May 2018
  593. MOON SH, Huang E
    Lipopeptide Paenipeptin Analogues Potentiate Clarithromycin and Rifampicin against Carbapenem-Resistant Pathogens.
    Antimicrob Agents Chemother. 2018 May 29. pii: AAC.00329.
    >> Share

  594. ZONG Z, Jing W, Shi J, Wen S, et al
    Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China.
    Antimicrob Agents Chemother. 2018 May 29. pii: AAC.00165.
    >> Share

  595. SAVAGE KA, Parquet MDC, Allan DS, Davidson RJ, et al
    Iron restriction to clinical isolates of Candida albicans by the novel chelator DIBI inhibits growth and increases sensitivity to azoles in vitro and in vivo in a murine model of experimental vaginitis.
    Antimicrob Agents Chemother. 2018 May 29. pii: AAC.02576.
    >> Share

  596. JAHANBAKHSH S, Singh NB, Yim J, Rose WE, et al
    Evaluation of Telavancin Alone and Combined with Ceftaroline or Rifampin against Methicillin-Resistant Staphylococcus aureus (MRSA) in an in vitro Biofilm Model.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00567.
    >> Share

  597. BROWN GANDT A, Griffith EC, Lister IM, Billings LL, et al
    In vivo and in vitro effects of a ClpP activating antibiotic against vancomycin resistant enterococci.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00424.
    >> Share

  598. GOEMAERE B, Lagrou K, Spriet I, Hendrickx M, et al
    Clonal spread in Candida glabrata bloodstream isolates and fluconazole resistance affected by prolonged exposure: a 12-year single-center study in Belgium.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00591.
    >> Share

  599. AHMED MN, Porse A, Sommer MOA, Hoiby N, et al
    Evolution of antibiotic resistance in biofilm and planktonic P. aeruginosa populations exposed to sub-inhibitory levels of ciprofloxacin.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00320.
    >> Share

  600. HUANG HH, Lin YT, Chen PY, Li LH, et al
    ClpA and HtpX Proteases Are Involved in Intrinsic Aminoglycoside Resistance of Stenotrophomonas maltophilia and Are Potential Aminoglycoside Adjuvant Targets.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00554.
    >> Share

  601. CHEN K, Dong N, Zhao S, Liu L, et al
    Identification and characterization of conjugative plasmids that encode ciprofloxacin resistance in Salmonella.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00575.
    >> Share

  602. MISIC D, Asanin J, Spergser J, Szostak M, et al
    OXA-72-mediated carbapenem resistance in sequence type 1 multidrug (colistin)-resistant Acinetobacter baumannii associated with urinary tract infection in a dog from Serbia.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00219.
    >> Share

  603. LUO J, Yu X, Jiang G, Fu Y, et al
    In Vitro Activity of Clofazimine against Non-tuberculous Mycobacteriaisolated in Beijing, China.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00072.
    >> Share

  604. KEBRIAEI R, Rice SA, Singh KV, Stamper KC, et al
    Efficacy of Daptomycin Monotherapy and In Combination with beta-lactams for Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions: Influence of The Inoculum Effect.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00315.
    >> Share

  605. KASPAR U, de Haro Sautto JA, Molinaro S, Peters G, et al
    The novel phage-derived antimicrobial agent HY-133 is active against livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA).
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00385.
    >> Share

  606. BOUDJEMAA R, Cabriel C, Dubois-Brissonnet F, Bourg N, et al
    Failure of daptomycin to kill Staphylococcus aureus: impact of bacterial membrane fatty acid composition.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00023.
    >> Share

    April 2018
  607. FENG Y, Lu Y, Yao Z, Zong Z, et al
    Carbapenem-resistant hypervirulent Klebsiella pneumoniae of sequence type 36.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.02644.
    >> Share

  608. BUTTS A, Reitler P, Ge W, Fortwendel JR, et al
    Commonly used oncology drugs decrease antifungal effectiveness against Candida and Aspergillus species.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00504.
    >> Share

  609. SHI W, Chen J, Zhang S, Zhang W, et al
    Identification of novel mutations in LprG (rv1411c), rv0521,rv3630, rv0010c, ppsC,cyp128 associated with pyrazinoic acid/pyrazinamide resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Apr 23. pii: AAC.00430.
    >> Share

  610. BUTLER-LAPORTE G, Lee TC, Cheng MP
    Increasing Rates of Penicillin Sensitivity in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Apr 23. pii: AAC.00680.
    >> Share

  611. STEFAN MA, Ugur FS, Garcia GA
    SOURCE OF THE FITNESS DEFECT IN RIFAMYCIN-RESISTANT M. TUBERCULOSIS RNA POLYMERASE AND THE MECHANISM OF COMPENSATION BY MUTATIONS IN THE beta'-SUBUNIT.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00164.
    >> Share

  612. RUDRA P, Hurst-Hess K, Lappierre P, Ghosh P, et al
    High levels of intrinsic tetracycline resistance in Mycobacterium abscessus is conferred by a tetracycline- modifying monooxygenase.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.00119.
    >> Share

  613. KORDALEWSKA M, Lee A, Park S, Berrio I, et al
    Understanding echinocandin resistance in the emerging pathogen Candida auris.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.00238.
    >> Share

  614. GARCIA-RUBIO R, Alcazar-Fuoli L, Monteiro MC, Monzon S, et al
    Aspergillus fumigatus cyp51A polymorphisms, an insight on their significance.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.00241.
    >> Share

  615. BARMAN TK, Kumar M, Mathur T, Namba E, et al
    In vitro and in vivo activities of DS-2969b, a novel GyrB inhibitor, and its water-soluble prodrug, DS11960558, against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02556.
    >> Share

  616. GARCIA-DE-LA-MARIA C, Gasch O, Garcia-Gonzalez J, Soy D, et al
    The Combination of Daptomycin plus Fosfomycin has Synergistic, Potent and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) in a Rabbit Model of Experimental Endocarditis (EE).
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02633.
    >> Share

  617. LU L, Feng Y, Long H, McNally A, et al
    ST273 carbapenem-resistant Klebsiella pneumoniae carrying blaNDM-1 and blaIMP-4.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00160.
    >> Share

  618. SINGH A, Healey KR, Yadav P, Upadhyaya G, et al
    Absence of azole or echinocandin resistance in Candida glabrata isolates in India despite background prevalence of strains with defects in DNA mismatch repair pathway.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00195.
    >> Share

  619. GSALLER F, Furukawa T, Carr PD, Rash B, et al
    The mechanistic basis of pH-dependent 5-flucytosine resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02593.
    >> Share

  620. BASSO V, Garcia A, Tran DQ, Schaal JB, et al
    Fungicidal potency and mechanisms of theta-defensins against multi-drug resistant Candida species.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00111.
    >> Share

  621. KARVANEN M, Malmberg C, Lagerback P, Friberg LE, et al
    Reply to Prim et al., "Is Colistin Susceptibility Testing Finally on the Right Track?"
    Antimicrob Agents Chemother. 2018;62.
    >> Share

    March 2018
  622. HOU X, Xiao M, Wang H, Yu SY, et al
    Profiling of PDR1 and MSH2 in Candida glabrata Bloodstream Isolates from a Multi-Center Study in China.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.00153.
    >> Share

  623. PARDOS DE LA GANDARA M, Borges V, Chung M, Milheirico C, et al
    Genetic determinants of high-level oxacillin resistance in MRSA.
    Antimicrob Agents Chemother. 2018 Mar 19. pii: AAC.00206.
    >> Share

  624. TOMAS ME, Mana TSC, Wilson BM, Nerandzic MM, et al
    Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota that Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.02237.
    >> Share

  625. SMITH JR, Yim J, Rice S, Stamper K, et al
    The combination of tedizolid and daptomycin against methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.00101.
    >> Share

  626. EVERETT M, Sprynski N, Coelho A, Castandet J, et al
    Discovery of a Novel Metallo-ss-Lactamase Inhibitor, which can Potentiate Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.00074.
    >> Share

  627. SHIELDS RK, Nguyen MH, Chen L, Press EG, et al
    Pneumonia and renal replacement therapy are risk factors for ceftazidime-avibactam treatment failures and resistance among patients with carbapenem-resistant Enterobacteriaceae infections.
    Antimicrob Agents Chemother. 2018 Mar 5. pii: AAC.02497.
    >> Share

  628. CHEN Y, Li Z, Han X, Tian S, et al
    Elevated MIC values to imidazole drugs among Aspergillus fumigatus isolates with TR34/L98H/S297T/F495I mutation.
    Antimicrob Agents Chemother. 2018 Mar 5. pii: AAC.01549.
    >> Share

    February 2018
  629. LU Z, Jia X, Chen Y, Han X, et al
    Identification and Characterization of Key Charged Residues in the Cofilin Protein Involved in Azole Susceptibility, Apoptosis, and Virulence of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.01659.
    >> Share

  630. BERKOW EL, Nunnally NS, Bandea A, Kuykendall R, et al
    Detection of TR34/L98H Cyp51A mutation through passive surveillance for azole-resistant Aspergillus fumigatus in the US, 2015-2017.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02240.
    >> Share

  631. DELINO NS, Aoki M, Hayashi H, Hattori SI, et al
    GRL-079, a novel P2-Tp-THF-C5-alkylamine- and P2' -Abt-containing HIV-1 protease inhibitor, is extremely potent against multi-drug-resistant HIV-1 variants including HIVDRV(R)p51 and has a high genetic barrier against the emergence of resistant varian
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02060.
    >> Share

  632. MURATA M, Kosai K, Yamauchi S, Sasaki D, et al
    In vitro activity of lascufloxacin against Streptococcus pneumoniae with mutations in the quinolone resistance-determining regions (QRDRs).
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.01971.
    >> Share

  633. COLLEY T, Sehra G, Chowdhary A, Alanio A, et al
    In Vitro and In Vivo Efficacy of a Novel and Long Acting Fungicidal Azole, PC1244 on Aspergillus fumigatus Infection.
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.01941.
    >> Share

  634. LAU CH, Topp E
    Towards understanding the "proline-centric" design of a peptide-mediated macrolide resistance mechanism.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.02618.
    >> Share

  635. ESPINEL-INGROFF A, Turnidge J, Alastruey-Izquierdo A, Dannaoui E, et al
    Posaconazole MIC distributions for Aspergillus fumigatus SC by four methods: Impact of Cyp51A mutations on estimation of epidemiological cutoff values (ECVs/ECOFFs).
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01916.
    >> Share

  636. KHAN Z, Ahmad S, Mokaddas E, Meis JF, et al
    Development of echinocandin resistance in Candida tropicalis following short-term exposure to caspofungin for empiric therapy.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01926.
    >> Share

  637. RIAT A, Plojoux J, Gindro K, Schrenzel J, et al
    Azole resistance of Aspergillus fumigatus isolates from the environment and the clinic in Switzerland.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.02088.
    >> Share

    January 2018
  638. ADANI S, Bhowmick T, Weinstein MP, Narayanan N, et al
    Clinical Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin at an Institution with Suppressed MIC Reporting: Impact of Vancomycin MIC.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02512.
    >> Share

  639. BRITT NS, Ritchie DJ, Kollef MH, Burnham CD, et al
    Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02400.
    >> Share

  640. UCHIYA KI, Asahi S, Futamura K, Hamaura H, et al
    Antibiotic susceptibility and genotyping of Mycobacterium avium strains that cause pulmonary and disseminated infection.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02035.
    >> Share

  641. SUWUNNAKORN S, Wakabayashi H, Kordalewska M, Perlin DS, et al
    FKS2 and FKS3 genes of opportunistic human pathogen Candida albicans influence echinocandin susceptibility.
    Antimicrob Agents Chemother. 2018 Jan 22. pii: AAC.02299.
    >> Share

  642. NEEMUCHWALA A, Soares D, Ravirajan V, Marchand-Austin A, et al
    In vitro antibiotic susceptibility pattern of Non-diphtheriae Corynebacterium in Ontario, 2011-2016.
    Antimicrob Agents Chemother. 2018 Jan 16. pii: AAC.01776.
    >> Share

  643. LANDERSDORFER CB, Yadav R, Rogers KE, Kim TH, et al
    Combating carbapenem-resistant Acinetobacter baumannii by an optimized imipenem plus tobramycin dosage regimen - prospective validation via hollow fiber infection and mathematical modeling.
    Antimicrob Agents Chemother. 2018 Jan 16. pii: AAC.02053.
    >> Share

  644. CHACKO K, Sullivan M, Beckford C, Altman D, et al
    The genetic basis of emerging vancomycin, linezolid, and daptomycin heteroresistance in a case of persistent Enterococcus faecium bacteremia.
    Antimicrob Agents Chemother. 2018 Jan 16. pii: AAC.02007.
    >> Share

  645. TOP J, Sinnige JC, Brouwer EC, Werner G, et al
    Identification of a novel genomic island associated with vanD-type vancomycin-resistance in six Dutch vancomycin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01793.
    >> Share

  646. DESMET S, Nepal S, van Dijl JM, Van Ranst M, et al
    Antibiotic resistance plasmids cointegrated into a megaplasmid harbouring the blaOXA-427 carbapenemase gene.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01448.
    >> Share

  647. SHARMA C, Kumar R, Kumar N, Masih A, et al
    Investigation of multiple resistance mechanisms in voriconazole resistant Aspergillus flavus clinical isolates from a chest hospital surveillance in Delhi, India.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01928.
    >> Share

  648. LONG N, Zeng L, Qiao S, Li L, et al
    Aspergillus fumigatus Afssn3-Afssn8 Pair Reverse regulates Azole Resistance by Conferring Extracellular Polysaccharide, Sphingolipid Pathway Intermediates and Efflux Pumps to Biofilm.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01978.
    >> Share

  649. YU SJ, Chang YL, Chen YL
    Deletion of ADA2 increases antifungal drug susceptibility and virulence in Candida glabrata.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01924.
    >> Share

  650. BORDALLO-CARDONA MA, Marcos-Zambrano LJ, Sanchez-Carrillo C, de la Pedrosa EGG, et al
    Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical Candida glabrata isolates.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01982.
    >> Share

  651. BHATTACHARYA S, Fries BC
    Enhanced Efflux Pump Activity in Old Candida glabrata.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.02227.
    >> Share

  652. VILCHEZE C, Kim J, Jacobs WR Jr
    Vitamin C potentiates the killing of Mycobacterium tuberculosis by the first-line tuberculosis drugs isoniazid and rifampicin in mice.
    Antimicrob Agents Chemother. 2018 Jan 3. pii: AAC.02165.
    >> Share

    December 2017
  653. IKEH MAC, Fidel PL Jr, Noverr MC
    Prostaglandin E2 Receptor Antagonist with Antimicrobial Activity Against Methicillin Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.01920.
    >> Share

  654. GREENFIELD BK, Shaked S, Marrs CF, Nelson P, et al
    Modeling the emergence of antibiotic resistance in the environment: an analytical solution for the minimum selection concentration.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.01686.
    >> Share

  655. AUNG WW, Ei PW, Nyunt WW, Htwe MM, et al
    Pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Myanmar.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.01984.
    >> Share

  656. SADER HS, Mendes RE, Duncan LR, Pfaller MA, et al
    Antimicrobial Activity of Dalbavancin Tested against Staphylococcus aureus with Decreased Susceptibility to Glycopeptides, Daptomycin, and/or Linezolid from United States Medical Centers.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.02397.
    >> Share

  657. CARTER GP, Schultz MB, Baines SL, Goncalves da Silva A, et al
    Topical antibiotic use co-selects for the carriage of mobile genetic elements conferring resistance to unrelated antimicrobials in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Dec 11. pii: AAC.02000.
    >> Share

  658. RIMBARA E, Mori S, Kim H, Suzuki M, et al
    Mutations in Genes Encoding Penicillin-Binding Proteins and Efflux Pumps Play a Role in beta-Lactam Resistance in Helicobacter cinaedi.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.02036.
    >> Share

  659. ZHANG Y, Wang Q, Yin Y, Chen H, et al
    Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from China CRE Network.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.01882.
    >> Share

  660. WU CJ, Chiu TT, Lin YT, Huang YW, et al
    Role of smeU1VWU2X Operon in the Alleviation of Oxidative Stresses and the Occurrence of Sulfamethoxazole/trimethoprim-resistant Mutants in Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.02114.
    >> Share

  661. LEE H, Ahn S, Hwang NY, Jeon K, et al
    Limited Effect of Later-generation Fluoroquinolones in the Treatment of Ofloxacin-resistant and Moxifloxacin-susceptible Multidrug-resistant Tuberculosis.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.01784.
    >> Share

    November 2017
  662. CHANNABASAPPA S, Durgaiah M, Chikkamadaiah R, Kumar S, et al
    Efficacy of novel anti-staphylococcal ectolysin P128 in a rat model of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia.
    Antimicrob Agents Chemother. 2017 Nov 27. pii: AAC.01358.
    >> Share

  663. WILLIAMSON DA, Lane CR, Easton M, Valcanis M, et al
    Increasing antimicrobial resistance in non-typhoidal Salmonella in Australia, 1979 - 2015.
    Antimicrob Agents Chemother. 2017 Nov 27. pii: AAC.02012.
    >> Share

  664. GOLDSTEIN EJC, Citron DM, Tyrrell KL, Leoncio E, et al
    The comparative in vitro activity of relebactam, imipenem and the combination of the two, plus six comparator antimicrobial agents against 432 strains of anaerobic organisms including imipenem-resistant strains.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.01992.
    >> Share

  665. PATHIRANA RU, Friedman J, Norris HL, Salvatori O, et al
    Fluconazole Resistant Candida auris is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.01872.
    >> Share

  666. ABBADI BL, Villela AD, Rodrigues-Junior VS, Subtil FT, et al
    Revisiting activation of and the mechanism of resistance to the compound IQG-607 in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.02222.
    >> Share

  667. ZHENG X, Berti AD, McCrone S, Roch M, et al
    Combination antibiotic exposure selectively alters the development of vancomycin intermediate resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.02100.
    >> Share

  668. TRUONG J, Veillette JJ, Forland SC
    Outcomes of vancomycin plus a beta-lactam versus vancomycin only for the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01554.
    >> Share

  669. SABET M, Tarazi Z, Rubio-Aparicio D, Nolan TG, et al
    Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-resistant Enterobacteriaceae in an In Vitro Hollow Fiber Model.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01969.
    >> Share

  670. WI YM, Greenwood-Quaintance KE, Schuetz AN, Ko KS, et al
    Activity of Ceftolozane/Tazobactam Against Carbapenem-Resistant, Carbapenemase Non-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01970.
    >> Share

  671. BOLARD A, Plesiat P, Jeannot K
    Mutations in gene fusA1 as a novel mechanism of aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01835.
    >> Share

  672. CHANDRA J, Ghannoum MA
    CD101, a Novel Echinocandin Possesses Potent Anti-biofilm Activity Against Early and Mature Candida albicans Biofilms.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01750.
    >> Share

  673. EL-HOSSARY EM, Forstner KU, Francois P, Baud D, et al
    A Novel Mechanism of Inactivating Antibacterial Nitro Compounds in the Human Pathogen Staphylococcus aureus by Overexpression of a NADH-dependent Flavin Nitroreductase.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01510.
    >> Share

  674. HEYCKENDORF J, Andres S, Koser CU, Olaru ID, et al
    What is resistance? Impact of phenotypic versus molecular drug resistance testing on multi- and extensively drug-resistant tuberculosis therapy.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01550.
    >> Share

  675. BELLEY A, Arhin FA, Moeck G
    Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an in vitro Pharmacokinetic/Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2017 Nov 6. pii: AAC.01873.
    >> Share

  676. SABET M, Tarazi Z, Nolan T, Parkinson J, et al
    Activity of Meropenem-Vaborbactam in Mouse Models of Infection due to KPC-producing Carbapenem-Resistant Enterobacteriaceae (CRE).
    Antimicrob Agents Chemother. 2017 Nov 6. pii: AAC.01446.
    >> Share

  677. GARDNER SG, Marshall DD, Daum RS, Powers R, et al
    Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility.
    Antimicrob Agents Chemother. 2017 Nov 6. pii: AAC.01608.
    >> Share

    October 2017
  678. SUN Q, Xiao TY, Liu HC, Zhao XQ, et al
    Mutations within embCAB are associated with variable level of ethambutol resistance in Mycobacterium tuberculosis isolates from China.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01279.
    >> Share

  679. WILLBY MJ, Wijkander M, Havumaki J, Johnson K, et al
    Detection of Mycobacterium tuberculosis pncA mutations by the NIPRO GenoscholarPZA-TB II as compared to conventional sequencing.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01871.
    >> Share

  680. ARGUDIN MA, Roisin S, Dodemont M, Nonhoff C, et al
    Mutations at the ribosomal S10 gene in clinical strains of Staphylococcus aureus with reduced susceptibility to tigecycline.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01852.
    >> Share

  681. DE SILVA PM, Chong P, Fernando DM, Westmacott G, et al
    Effect of incubation temperature on antibiotic resistance and virulence factors of Acinetobacter baumannii ATCC 17978.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01514.
    >> Share

  682. DAL MOLIN M, Gut M, Rominski A, Haldimann K, et al
    Molecular Mechanisms of Intrinsic Streptomycin Resistance in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01427.
    >> Share

  683. SAPUTO S, Faustoferri RC, Quivey RG Jr
    Vitamin D compounds are bactericidal against Streptococcus mutans and target the bacitracin-associated efflux system.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01675.
    >> Share

  684. BHARDWAJ P, Hans A, Ruikar K, Guan Z, et al
    Reduced chlorhexidine and daptomycin susceptibility in vancomycin-resistant Enterococcus faecium after serial chlorhexidine exposure.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01235.
    >> Share

  685. JONES D, Elshaboury RH, Munson E, Dilworth TJ, et al
    A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable mecA by a Commercial PCR Assay Compared to Patients with Methicillin-resistant Sta
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01396.
    >> Share

  686. WEISS WJ, Pulse ME, Nguyen P, Peterson K, et al
    Activity of Meropenem-Vaborbactam Against Carbapenem-resistant Enterobacteriaceae in a Murine Model of Pyelonephritis.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01439.
    >> Share

  687. VAN LOON K, Voor In 't Holt AF, Vos MC
    Clinical epidemiology of carbapenem-resistant Enterobacteriaceae: a systematic review and meta-analyses.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01730.
    >> Share

  688. ACCOCEBERRY I, Rougeron A, Biteau N, Chevrel P, et al
    A CTG clade Candida yeast genetically engineered for the genotype-phenotype characterization of azole antifungal resistance in human pathogenic yeasts.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01483.
    >> Share

  689. XU J, Tasneen R, Peloquin CA, Almeida DV, et al
    Verapamil increases the bioavailability and efficacy of bedaquiline but not clofazimine in a murine model of tuberculosis.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01692.
    >> Share

  690. RAFFETIN A, Courbin V, Jullien V, Dannaoui E, et al
    In vitro combination of Isavuconazole with Echinocandins against Azole-Susceptible and -Resistant Aspergillus spp.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01382.
    >> Share

  691. HUMPHRIES RM, Hindler JA, Wong-Beringer A, Miller SA, et al
    Activity of ceftolozane-tazobactam and ceftazidime-avibactam against beta-lactam resistant Pseudomonas aeruginosa isolates.
    Antimicrob Agents Chemother. 2017 Oct 9. pii: AAC.01858.
    >> Share

  692. DE WELZEN L, Eldholm V, Maharaj K, Manson AL, et al
    Whole transcriptome and genomic analysis of extensively drug-resistant Mycobacterium tuberculosis clinical isolates identifies downregulation of ethA as a mechanism of ethionamide resistance.
    Antimicrob Agents Chemother. 2017 Oct 9. pii: AAC.01461.
    >> Share

  693. MOUSAVI SF, Pana M, Feizabadi M, Jalali P, et al
    Diversity of mosaic pbp2x families of penicillin-resistant Streptococcus pneumoniae from Iran and Romania.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01535.
    >> Share

  694. CHIOTOS K, Tamma PD, Flett KB, Naumann M, et al
    Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children: a Multicenter Study.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01440.
    >> Share

  695. NAKATANI Y, Opel-Reading HK, Merker M, Machado D, et al
    Role of alanine racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01575.
    >> Share

  696. HEALEY KR, Nagasaki Y, Zimmerman M, Kordalewska M, et al
    The gastrointestinal tract is a major source of echinocandin drug resistance in a murine model of Candida glabrata colonization and systemic dissemination.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01412.
    >> Share

    September 2017
  697. LIU BH, Lei CW, Zhang AY, Pan Y, et al
    Co-location of the multiresistance gene cfr and the fosfomycin resistance gene fosD on a novel plasmid in Staphylococcus arlettae from chicken farm.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01388.
    >> Share

  698. HASSOUNAH SA, Alikhani A, Oliveira M, Bharaj S, et al
    Antiviral Activity of Bictegravir and Cabotegravir Against Integrase Inhibitor Resistant SIVmac239 and HIV-1.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01695.
    >> Share

  699. BUIL JB, van der Lee HAL, Rijs AJMM, Zoll J, et al
    AGAR-BASED SCREENING FOR AZOLE RESISTANCE IN ASPERGILLUS FUMIGATUS USING VIPcheck: A SINGLE CENTRE EVALUATION.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01250.
    >> Share

  700. JIMENEZ-ORTIGOSA C, Moore C, Denning DW, Perlin DS, et al
    Emergence of Echinocandin Resistance due to a Point Mutation in the fks1 Gene of Aspergillus fumigatus in a Patient with Chronic Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01277.
    >> Share

  701. XU W, DeJesus MA, Rucker N, Engelhart CA, et al
    Chemical genomic interaction profiling reveals determinants of intrinsic antibiotic resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01334.
    >> Share

  702. KNOPPEL A, Nasvall J, Andersson DI
    Evolution of antibiotic resistance without antibiotic exposure.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01495.
    >> Share

  703. METCALFE JZ, Streicher E, Theron G, Colman RE, et al
    Mycobacterium tuberculosis subculture results in loss of potentially clinically relevant heteroresistance.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00888.
    >> Share

  704. NEGRI CE, Goncalves SS, Sousa ACP, Bergamasco MD, et al
    Triazole resistance is still not emerging in A fumigatus isolates causing invasive aspergillosis in Brazilian patients.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00608.
    >> Share

  705. ZHAO N, Wang G, Das AT, Berkhout B, et al
    Combinatorial CRISPR-Cas9 and RNAi attack on HIV-1 DNA and RNA can lead to cross-resistance.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01486.
    >> Share

  706. BERNAL-MARTINEZ L, Gil H, Rivero-Menendez O, Gago S, et al
    Development and validation of a High Resolution Melting Assay to detect azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01083.
    >> Share

  707. HOBDEY SE, Katahira EJ, Dockstader P, Davidson SM, et al
    Subinhibitory Dalbavancin Attenuates Exotoxin Production from Methicillin-sensitive and Methicillin-resistant Staphylococcus aureus in vitro.
    Antimicrob Agents Chemother. 2017 Sep 5. pii: AAC.01090.
    >> Share

  708. HURST-HESS K, Rudra P, Ghosh P
    Mycobacterium abscessus WhiB7 regulates a species -specific repertoire of genes to confer extreme antibiotic resistance.
    Antimicrob Agents Chemother. 2017 Sep 5. pii: AAC.01347.
    >> Share

  709. SCHNIEDERJANS M, Koska M, Haussler S
    Transcriptional and mutational profiling of an aminoglycoside resistant Pseudomonas aeruginosa small colony variant.
    Antimicrob Agents Chemother. 2017 Sep 5. pii: AAC.01178.
    >> Share

  710. PARK SW, Tasneen R, Converse PJ, Nuermberger EL, et al
    Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 5. pii: AAC.01502.
    >> Share

    August 2017
  711. MCMULLEN AR, Anderson N, Wallace MA, Shupe A, et al
    When Good Bugs Go Bad: Epidemiology and Antimicrobial Resistance Profiles of Corynebacterium striatum, an Emerging Multidrug Resistant, Opportunistic Pathogen.
    Antimicrob Agents Chemother. 2017 Aug 28. pii: AAC.01111.
    >> Share

  712. SHEKHOVA E, Kniemeyer O, Brakhage AA
    Induction of mitochondrial ROS production by itraconazole, terbinafine and amphotericin B as a mode of action against Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2017 Aug 28. pii: AAC.00978.
    >> Share

  713. FAKHIM H, Chowdhary A, Prakash A, Vaezi A, et al
    In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris.
    Antimicrob Agents Chemother. 2017 Aug 28. pii: AAC.01056.
    >> Share

  714. VALENTINE-KING MA, Brown MB
    Antibacterial Resistance in Ureaplasma species and Mycoplasma hominis Isolates from Urine Cultures in College-aged Females.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.01104.
    >> Share

  715. KATAYAMA Y, Azechi T, Miyazaki M, Takata T, et al
    Prevalence of Slow-growth Vancomycin Non-susceptibility In Methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.00452.
    >> Share

  716. CHOU S
    Comparison of Cytomegalovirus Terminase Gene Mutations Selected after Exposure to Three Distinct Inhibitor Compounds.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.01325.
    >> Share

  717. SCHELL WA, Jones AM, Borroto-Esoda K, Alexander BD, et al
    Antifungal Activity of SCY-078 and Standard Antifungal Agents Against 178 Clinical Isolates of Resistant and Susceptible Candida Species.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.01102.
    >> Share

  718. CHEUNG YY, Hui M
    Effects of Echinocandins in combination with Nikkomycin Z against invasive Candida albicans bloodstream isolates and the fks mutants.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.00619.
    >> Share

  719. CHATTERJEE SS, Chen L, Gilbert A, da Costa TM, et al
    PBP4 mediates beta-lactam resistance by altered function.
    Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.00932.
    >> Share

  720. TSAY FW, Wu DC, Yu HC, Kao SS, et al
    Both 14-day hybrid and bismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with moderate antibiotic resistance: a randomized controlled trial.
    Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.00140.
    >> Share

  721. MELETIADIS J, Turlej-Rogacka A, Lerner A, Adler A, et al
    Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone.
    Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.00473.
    >> Share

  722. LIU Z, Myers LC
    Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-induced MDR1 Expression and Fluconazole Resistance.
    Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.01344.
    >> Share

  723. LIU Z, Myers LC
    Mediator Tail Module is Required for Tac1 Activated CDR1 Expression and Azole Resistance in Candida albicans.
    Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.01342.
    >> Share

  724. PIRET J, Goyette N, Boivin G
    Drug Susceptibility and Replicative Capacity of Multi-Drug Resistant Recombinant Human Cytomegalovirus Harboring Mutations in UL56 and UL54 Genes.
    Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.01044.
    >> Share

  725. MCBRIDE JM, Lim JJ, Burgess T, Deng R, et al
    Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Challenge Model: A Phase 2 Randomized Trial.
    Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.01154.
    >> Share

  726. RENZONI A, Von Dach E, Landelle C, Diene SM, et al
    Impact of exposure of methicillin-resistant Staphylococcus aureus to polyhexanide in vitro and in vivo.
    Antimicrob Agents Chemother. 2017 Aug 7. pii: AAC.00272.
    >> Share

  727. BELLEY A, Lalonde-Seguin D, Arhin FF, Moeck G, et al
    Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-resistant Enterococcus faecium Isolates in an In Vitro PK/PD Model of Infection.
    Antimicrob Agents Chemother. 2017 Aug 7. pii: AAC.01265.
    >> Share

  728. TYSON GH, Tate HP, Zhao S, Li C, et al
    Identification of Plasmid-Mediated Quinolone Resistance in Salmonella Isolated from Swine Ceca and Retail Pork Chops in the United States.
    Antimicrob Agents Chemother. 2017 Aug 7. pii: AAC.01318.
    >> Share

  729. CASTANHEIRA M, Deshpande LM, Davis AP, Rhomberg PR, et al
    Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Moulds: Application of CLSI Epidemiological Cutoff Values and Whole Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Antimicrob Agents Chemother. 2017 Aug 7. pii: AAC.00906.
    >> Share

  730. ROSSLER S, Bader O, Stolzel F, Sommer U, et al
    Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a cyp51A TR46 Y121F M172I T289A Allele.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

    July 2017
  731. YAMADA K, Saito R, Muto S, Kashiwa M, et al
    Molecular characterization of fluoroquinolone-resistant Moraxella catarrhalis variants generated in vitro by stepwise selection.
    Antimicrob Agents Chemother. 2017 Jul 31. pii: AAC.01336.
    >> Share

  732. MCNEIL MB, Dennison D, Shelton C, Parish T, et al
    In vitro isolation and characterization of oxazolidinone resistant Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Jul 31. pii: AAC.01296.
    >> Share

  733. CHHIBBER S, Shukla A, Kaur S
    Transfersomal phage cocktail: an effective treatment against methicillin resistant S.aureus (MRSA) mediated Skin and Soft tissue infections (SSTIs).
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.02146.
    >> Share

  734. CHOI H, Kim SY, Kim DH, Huh HJ, et al
    Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-resistant Mycobacterium abscessus Lung Disease.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.01146.
    >> Share

  735. WANG P, McElheny CL, Mettus RT, Shanks RMQ, et al
    Contribution of TetB Efflux Pump on Minocycline Susceptibility among Carbapenem-Resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.01176.
    >> Share

  736. JUKIC E, Blatzer M, Posch W, Steger M, et al
    Oxidative stress response tips the balance in Aspergillus terreus AmB resistance.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.00670.
    >> Share

  737. PANG Y, Zong Z, Huo F, Jing W, et al
    In vitro drug susceptibility of bedaquiline, delamanid, linezolid, clofazimine, moxifloxacin, and gatifloxacin against extensively drug -resistant tuberculosis from Beijing, China.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.00900.
    >> Share

  738. GALLAGHER LA, Coughlan S, Black NS, Lalor P, et al
    Tandem amplification of SCCmec can drive high level methicillin resistance in MRSA.
    Antimicrob Agents Chemother. 2017 Jul 17. pii: AAC.00869.
    >> Share

  739. HEINE HS, Shadomy SV, Boyer AE, Chuvala L, et al
    Evaluation of Combination Drug Therapy for Treatment of Antibiotic Resistant Inhalation Anthrax in a Murine Model.
    Antimicrob Agents Chemother. 2017 Jul 10. pii: AAC.00788.
    >> Share

  740. HAZEN TH, Michalski J, Nagaraj S, Okeke IN, et al
    Characterization of a large antibiotic resistance plasmid found in enteropathogenic Escherichia coli strain B171 and its relatedness to plasmids of diverse E. coli and Shigella.
    Antimicrob Agents Chemother. 2017 Jul 3. pii: AAC.00995.
    >> Share

  741. HEINE HS, Miller L, Halasohoris S, Purcell BK, et al
    In Vitro Antibiotic Susceptibilities of Francisella tularensis by Broth Micro-Dilution Following CLSI Methods.
    Antimicrob Agents Chemother. 2017 Jul 3. pii: AAC.00612.
    >> Share

  742. HENNEBIQUE A, Bidart M, Jarraud S, Beraud L, et al
    Digital PCR for detection and quantification of fluoroquinolone resistance in Legionella pneumophila.
    Antimicrob Agents Chemother. 2017 Jul 3. pii: AAC.00628.
    >> Share

  743. LONG TE
    Repurposing thiram and disulfiram as antibacterial agents for multi-drug resistant Staphylococcus aureus infections.
    Antimicrob Agents Chemother. 2017 Jul 3. pii: AAC.00898.
    >> Share

  744. PATEL N, O'Malley T, Zhang YK, Xia Y, et al
    A novel 6-benzyl ether benzoxaborole is active against Mycobacterium tuberculosis in vitro.
    Antimicrob Agents Chemother. 2017 Jul 3. pii: AAC.01205.
    >> Share

    June 2017
  745. CASTANHEIRA M, Huband MD, Mendes RE, Flamm RK, et al
    Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide During 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2017 Jun 26. pii: AAC.00567.
    >> Share

  746. FERRER-GONZALEZ E, Kaul M, Parhi AK, LaVoie EJ, et al
    beta-Lactam Antibiotics with a High Affinity for PBP2 Act Synergistically with the FtsZ-Targeting Agent TXA707 against Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00863.
    >> Share

  747. KIM CK, Milheirico C, de Lencastre H, Tomasz A, et al
    Antibiotic resistance as a stress response: recovery of high-level oxacillin resistance in methicillin resistant S. aureus (MRSA) "auxiliary" (fem) mutants - by induction of the stringent stress response.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00313.
    >> Share

  748. HAIDAR G, Clancy CJ, Chen L, Samanta P, et al
    Identifying spectra of activity and therapeutic niches for ceftazidime-avibactam and imipenem-relebactam against carbapenem-resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00642.
    >> Share

  749. CHIBA N, Murayama SY, Morozumi M, Iwata S, et al
    Genome Evolution to Penicillin Resistance in Serotype 3 Streptococcus pneumoniae by Capsular Switching.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00478.
    >> Share

  750. DAVIDO B, Fellous L, Lawrence C, Maxime V, et al
    Ceftazidime-Avibactam and Aztreonam an interesting strategy to Overcome beta-Lactam Resistance Conferred by Metallo-beta-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.01008.
    >> Share

  751. MATSUMOTO S, Singley CM, Hoover J, Nakamura R, et al
    Efficacy of Cefiderocol against Carbapenem-resistant Gram-negative bacilli in Immunocompetent Rat Respiratory Tract Infection Models Recreating Human Plasma pharmacokinetics.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00700.
    >> Share

  752. RAHMAN A, Ferdous SS, Ahmed S, Rahman SMM, et al
    Pyrazinamide susceptibility and pncA mutation profile of Mycobacterium tuberculosis among multi-drug resistant tuberculosis patients in Bangladesh.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00511.
    >> Share

  753. JIMENEZ-ORTIGOSA C, Perez WB, Angulo D, Borroto-Esoda K, et al
    De novo acquisition of resistance to SCY-078 in Candida glabrata involves FKS mutations that both overlap and are distinct from those conferring echinocandin resistance.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00833.
    >> Share

  754. RYBAK JM, Dickens CM, Parker JE, Caudle K, et al
    Loss of C-5 sterol desaturase activity results in increased resistance to azole and echinocandin antifungals in a clinical isolate of Candida parapsilosis.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00651.
    >> Share

  755. BABLISHVILI N, Tukvadze N, Shashkina E, Mathema B, et al
    The impact of gyrB and eis mutations in improving second-line drug resistance detection among Mycobacterium tuberculosis isolates from Georgia.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.01921.
    >> Share

  756. TODD DA, Parlet CP, Crosby HA, Malone CL, et al
    Targeting quorum sensing signal biosynthesis to fight antibiotic resistant infections: Ambuic acid as a model inhibitor.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.00263.
    >> Share

  757. RODRIGUES FELIX C, Gupta R, Geden S, Roberts J, et al
    Selective Killing Of Dormant Mycobacterium tuberculosis By Marine Natural Products.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.00743.
    >> Share

  758. HASHIMOTO A, Hagiwara D, Watanabe A, Yahiro M, et al
    Drug sensitivity and resistance mechanism in Aspergillus section Nigri strains from Japan.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.02583.
    >> Share

  759. LI DD, Chai D, Huang XW, Guan SX, et al
    Potent In Vitro Synergism of Fluconazole and Osthole against Fluconazole-Resistant Candida albicans.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.00436.
    >> Share

  760. ZHANG Y, Zhang J, Cui P, Zhang W, et al
    Identification of novel efflux proteins Rv0191, Rv3756c, Rv3008 and Rv1667c involved in pyrazinamide resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.00940.
    >> Share

  761. HALL CW, Zhang L, Mah TF
    PA3225 is a transcriptional repressor of antibiotic resistance mechanisms in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.02114.
    >> Share

  762. KLEINERT F, Kallies R, Hort M, Zweynert A, et al
    Influence of IS256 on genome variability and formation of SCV in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.00144.
    >> Share

  763. LEPAK AJ, Zhao M, Berkow EL, Lockhart SR, et al
    Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.00791.
    >> Share

  764. SRIVASTAVA S, Magombedze G, Koeuth T, Sherman C, et al
    Linezolid dose that maximizes sterilizing effect while minimizing toxicity and resistance emergence for tuberculosis.
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.00751.
    >> Share

  765. LE A, Farmakiotis D, Tarrand JJ, Kontoyiannis DP, et al
    Initial treatment of cancer patients with fluconazole susceptible dose-dependent Candida glabrata fungemia: Better outcome with an echinocandin or polyene compared to an azole?
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.00631.
    >> Share

  766. AZIZ DB, Low JL, Wu ML, Gengenbacher M, et al
    Rifabutin Is Active against Mycobacterium abscessus Complex.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  767. LIU X, Li R, Zheng Z, Chen K, et al
    Molecular Characterization of Escherichia coli Isolates Carrying mcr-1, fosA3, and Extended-Spectrum-beta-Lactamase Genes from Food Samples in China.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  768. CRUZ-OLIVEIRA C, Almeida AF, Freire JM, Caruso MB, et al
    Mechanisms of Vesicular Stomatitis Virus Inactivation by Protoporphyrin IX, Zinc-Protoporphyrin IX, and Mesoporphyrin IX.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  769. SHEA KM, Hobbs ALV, Jaso TC, Bissett JD, et al
    Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  770. KIEFFER N, Nordmann P, Poirel L
    Moraxella Species as Potential Sources of MCR-Like Polymyxin Resistance Determinants.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  771. KISHII R, Yamaguchi Y, Takei M
    In Vitro Activities and Spectrum of the Novel Fluoroquinolone Lascufloxacin (KRP-AM1977).
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  772. FLEEMAN R, Van Horn KS, Barber MM, Burda WN, et al
    Characterizing the Antimicrobial Activity of N(2),N(4)-Disubstituted Quinazoline-2,4-Diamines toward Multidrug-Resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  773. BARDET L, Baron S, Leangapichart T, Okdah L, et al
    Deciphering Heteroresistance to Colistin in a Klebsiella pneumoniae Isolate from Marseille, France.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  774. OVEJERO CM, Escudero JA, Thomas-Lopez D, Hoefer A, et al
    Highly Tigecycline-Resistant Klebsiella pneumoniae Sequence Type 11 (ST11) and ST147 Isolates from Companion Animals.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  775. LIU YY, Chandler CE, Leung LM, McElheny CL, et al
    Structural Modification of Lipopolysaccharide Conferred by mcr-1 in Gram-Negative ESKAPE Pathogens.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  776. MA Q, Xu X, Luo M, Wang J, et al
    A Waterborne Outbreak of Shigella sonnei with Resistance to Azithromycin and Third-Generation Cephalosporins in China in 2015.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  777. WIND CM, Bruisten SM, Schim van der Loeff MF, Dierdorp M, et al
    A Case-Control Study of Molecular Epidemiology in Relation to Azithromycin Resistance in Neisseria gonorrhoeae Isolates Collected in Amsterdam, the Netherlands, between 2008 and 2015.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

    May 2017
  778. LODISE T, Ye MJ, Zhao Q
    Prevalence of Invasive Infections due to Carbapenem-Resistant Enterobacteriaceae Among Adult Patients Across US Hospitals.
    Antimicrob Agents Chemother. 2017 May 30. pii: AAC.00228.
    >> Share

  779. ZHANG Y, Kashikar A, Brown CA, Denys G, et al
    An Unusual E. coli PBP3 Insertion Sequence Identified from a Collection of Carbapenem-Resistant Enterobacteriaceae (CRE) Tested in vitro with Ceftazidime-, Ceftaroline- or Aztreonam-Avibactam Combinations.
    Antimicrob Agents Chemother. 2017 May 30. pii: AAC.00389.
    >> Share

  780. SHIELDS RK, Nguyen MH, Chen L, Press EG, et al
    Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia.
    Antimicrob Agents Chemother. 2017 May 30. pii: AAC.00883.
    >> Share

  781. WU VH, Smith RA, Masoum S, Raugi DN, et al
    MK-8591 (4' -ethynyl-2-fluoro-2' -deoxyadenosine) exhibits potent activity against HIV-2 isolates and drug-resistant HIV-2 mutants in culture.
    Antimicrob Agents Chemother. 2017 May 30. pii: AAC.00744.
    >> Share

  782. AIGNER M, Erbeznik T, Gschwentner M, Lass-Florl C, et al
    Susceptibility testing of the echinocandins against Candida species in the daily routine: ETest(R) versus Sensititre YeastOne(R). Data from a single center in Austria.
    Antimicrob Agents Chemother. 2017 May 30. pii: AAC.00512.